About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Antipsychotic drugs
- Company
- Université de Sherbrooke
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 75 recruiting
Efficacy results: Not yet reported
75 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026
Find a Clinical Trial Near Me
See recruiting studies for Antipsychotic drugs and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT01246765
National Pregnancy Registry for Psychiatric Medications
Massachusetts General Hospital 5000 participants Est. completion 2033-12 1 siteOther conditions: Pregnant Women, Psychotropic DrugsView official trial listing → -
Recruiting NCT NCT02640911
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
Shanghai Mental Health Center 3000 participants Est. completion 2033-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Not yet reported Corporal Michael J. Crescenz VA Medical Center 10 participants Est. completion 2020-06-30 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Tobacco Smoking, Tardive Dyskinesia, ParkinsonismView official trial listing → -
Recruiting NCT NCT03911726
Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia
Not yet reported Central Institute of Mental Health, Mannheim 140 participants Est. completion 2028-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT04370730
Dimensional and Developmental Profiles of Psychosis in Children and Adolescents
Not yet reported Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2026-10-01 6 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Recruiting NCT NCT04373317
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Not yet reported VA Office of Research and Development 358 participants Est. completion 2028-08-24 24 sitesOther conditions: Parkinson's Disease PsychosisView official trial listing → -
Recruiting NCT NCT04478838
"Extended" (Alternate Day) Antipsychotic Dosing
Not yet reported Centre for Addiction and Mental Health 120 participants Est. completion 2028-09-30 1 siteOther conditions: Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic AgentsView official trial listing → -
Recruiting NCT NCT04580134
CLOZAPINE Response in Biotype-1
Not yet reported University of Texas Southwestern Medical Center 524 participants Est. completion 2027-04-30 5 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar 1 DisorderView official trial listing → -
Recruiting NCT NCT04996433
A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients
Not yet reported University of Greifswald 396 participants Est. completion 2028-04 8 sitesOther conditions: Persistent Depressive Disorder, Treatment-resistant DepressionView official trial listing → -
Recruiting NCT NCT05184335
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Not yet reported Reviva Pharmaceuticals 690 participants Est. completion 2025-02 18 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT05208190
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
Not yet reported New York State Psychiatric Institute 280 participants Est. completion 2028-12-31 7 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Recruiting NCT NCT05431595
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
Not yet reported, Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2027-02-02 1 siteOther conditions: Delirium, Epileptics, NeurolepticsView official trial listing → -
Recruiting NCT NCT05590637
Comparing Antipsychotic Medications in LBD Over Time
Not yet reported The University of Texas Health Science Center at San Antonio 94 participants Est. completion 2027-02 2 sitesOther conditions: Parkinson's Disease Psychosis, Dementia With Lewy BodiesView official trial listing → -
Recruiting NCT NCT05669742
Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
Not yet reported Tanta University 40 participants Est. completion 2026-12 1 siteOther conditions: Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by AntipsychoticsView official trial listing → -
Recruiting NCT NCT05728138
Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial
Not yet reported Pakistan Institute of Living and Learning 80 participants Est. completion 2025-10-30 1 siteOther conditions: Self Harm, First Episode PsychosisView official trial listing → -
Recruiting NCT NCT05744479
Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability
Not yet reported Centre for Addiction and Mental Health 100 participants Est. completion 2027-03-01 1 siteOther conditions: Intellectual Disability, Developmental Disability, ObesityView official trial listing → -
Recruiting NCT NCT05783063
iTBS for Increased Appetite Induced by Antipsychotics
Not yet reported Central South University 60 participants Est. completion 2026-08-01 2 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT05796401
Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis
Not yet reported Centre Hospitalier St Anne 500 participants Est. completion 2029-02-15 13 sitesOther conditions: PsychosisView official trial listing → -
Recruiting NCT NCT05942716
Serotonin Control of Impulsivity in Tourette Disorder
Not yet reported Hospices Civils de Lyon 25 participants Est. completion 2028-09-24 2 sitesOther conditions: Tourette DisorderView official trial listing → -
Recruiting NCT NCT05951660
Sex, Psychopharmacology, and Diabetes
Not yet reported Zealand University Hospital 256 participants Est. completion 2025-07-31 1 sitePrediabetes Other conditions: Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Diabetes Mellitus, Sexual Dysfunction, Drug-Related Side Effects and Adverse Reactions, EducationView official trial listing → -
Recruiting NCT NCT05958875
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Not yet reported Dr. Inge Winter 418 participants Est. completion 2028-06-30 13 sitesOther conditions: Schizophrenia and Related Disorders, Early Treatment-ResistanceView official trial listing → -
Recruiting NCT NCT05999240
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
Not yet reported New York State Psychiatric Institute 30 participants Est. completion 2027-12-31 2 sitesOther conditions: Autism Spectrum DisorderView official trial listing → -
Recruiting NCT NCT06049953
Maternal And Infant Antipsychotic Study
Icahn School of Medicine at Mount Sinai 74 participants Est. completion 2028-01-01 1 siteOther conditions: Antipsychotics, PregnancyView official trial listing → -
Recruiting NCT NCT06054321
Psychopharmacotherapy for Depressive Patients
Not yet reported Chonnam National University Hospital 400 participants Est. completion 2030-12-31 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Recruiting NCT NCT06123897
Establishing a Clinical Database and Biobank for Schizophrenia:A Cohort Study
Central South University 2000 participants Est. completion 2028-12-31 4 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06221852
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Not yet reported Mclean Hospital 50 participants Est. completion 2027-12-30 1 siteOther conditions: Bipolar I Disorder, Psychosis, Schizoaffective DisorderView official trial listing → -
Recruiting NCT NCT06333990
Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)
Not yet reported Foundation for Advancing Veterans' Health Research 146 participants Est. completion 2028-06 2 sitesOther conditions: Mild Traumatic Brain InjuryView official trial listing → -
Recruiting NCT NCT06431009
The Danish Region Midt Schizophrenia Cohort
University of Aarhus 350 participants Est. completion 2026-12-31 5 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06451952
Virtual Darkness Theraphy for Agitation in Dementia
Not yet reported University of Bergen 72 participants Est. completion 2027-12-31 1 siteOther conditions: Agitation in Dementia, Including Alzheimer's DiseaseView official trial listing → -
Recruiting NCT NCT06456983
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
Not yet reported Central Institute of Mental Health, Mannheim 140 participants Est. completion 2028-07 14 sitesOther conditions: Schizophrenia, Treatment Resistant SchizophreniaView official trial listing → -
Recruiting NCT NCT06482554
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
Not yet reported Louisiana State University Health Sciences Center Shreveport 80 participants Est. completion 2026-12 1 siteOther conditions: Apathy, Schizophrenia, Schizophrenia; PsychosisView official trial listing → -
Recruiting NCT NCT06560957
SYNCED - SYNChronized Eating in Bipolar Depression Study
Not yet reported University of Ottawa 40 participants Est. completion 2027-02-26 1 siteOther conditions: Bipolar Depression, Bipolar I Disorder, Bipolar II DisorderView official trial listing → -
Recruiting NCT NCT06580860
Psychiatric Multi-omics and Neuroimaging Project
mingjun Zhong 1899 participants Est. completion 2027-01 1 siteOther conditions: Mental Disorders, Healthy ControlView official trial listing → -
Recruiting NCT NCT06581302
Magnetic Seizure Therapy for Psychotic Disorders
Not yet reported Shanghai Jiao Tong University School of Medicine 50 participants Est. completion 2025-12-30 2 sites Stand-aloneOther conditions: Psychotic DisordersView official trial listing → -
Recruiting NCT NCT06613334
Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses
Not yet reported Centre Hospitalier St Anne 200 participants Est. completion 2027-10 2 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06617806
Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults
Not yet reported Nantes University Hospital 386 participants Est. completion 2027-10-31 1 siteOther conditions: Fall Prevention, Autonomy of Older People, Frail Elderly, Advanced Practice NursingView official trial listing → -
Recruiting NCT NCT06624462
Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic
Not yet reported Bjorn H. Ebdrup 84 participants Est. completion 2026-12-31 1 siteOther conditions: Severe Mental Disorder, Metabolic Complication, Side-Effect;Medication, Schizophrenia Spectrum and Other Psychotic Disorders, Bipolar DisorderView official trial listing → -
Recruiting NCT NCT06651112
The ATP Project (Antipsychotic-TEP-Psychosis)
Université de Sherbrooke 18 participants Est. completion 2028-06-01 1 siteOther conditions: First Episose Psychosis, Metabolic Disease, Psychosis; EpisodeView official trial listing → -
Recruiting NCT NCT06687694
Immune Mechanisms of Antipsychotic Treatment Response
King's College London 500 participants Est. completion 2031-07 1 siteOther conditions: PsychosisView official trial listing → -
Recruiting NCT NCT06729541
Development and Application of Precision Treatment Strategies for Common Mental Disorders
Not yet reported Peking University 600 participants Est. completion 2026-12 1 siteOther conditions: Depression - Major Depressive Disorder, Schizophrenia Disorders, Bipolar Disorder (BD)View official trial listing → -
Recruiting NCT NCT06729671
A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction
Not yet reported University College Cork 70 participants Est. completion 2026-11-30 2 sitesOther conditions: PsychosisView official trial listing → -
Recruiting NCT NCT06740890
Exercise and Olanzapine-samidorphan
Not yet reported New York State Psychiatric Institute 30 participants Est. completion 2027-04 1 siteOther conditions: Schizophenia Disorder, Schizoaffective Disorder, Bipolar Disorder I or II, Bipolar Disorder NOSView official trial listing → -
Recruiting NCT NCT06743711
Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project
Bjorn H. Ebdrup 75 participants Est. completion 2026-06-30 1 siteOther conditions: Severe Mental Illness, Schizophrenia Spectrum &Amp; Other Psychotic Disorders, Bipolar Affective DisorderView official trial listing → -
Recruiting NCT NCT06754319
Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
Shanghai Mental Health Center 125 participants Est. completion 2027-12-31 1 siteOther conditions: Obsessive-Compulsive Disorder, Tic DisorderView official trial listing → -
Recruiting NCT NCT06756139
Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia
Not yet reported Air Force Military Medical University, China 88 participants Est. completion 2025-11-01 7 sitesOther conditions: Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic DrugView official trial listing → -
Recruiting NCT NCT06814314
AP Metabolism Transcriptomics
IRCCS Eugenio Medea 100 participants Est. completion 2026-05 1 siteOther conditions: Neurodevelopmental Disorders, IrritabilityView official trial listing → -
Recruiting NCT NCT06831942
Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An Evaluation of a Psychosocial Intervention for Suicidal Adults Aged 65+
Not yet reported Vastra Gotaland Region 132 participants Est. completion 2031-06 2 sitesOther conditions: Suicidal Ideation, Suicide Attempt, SuicideView official trial listing → -
Recruiting NCT NCT06904079
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
Not yet reported Shanghai Mental Health Center 82 participants Est. completion 2026-06-30 1 site Stand-aloneOther conditions: Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder, Paranoid Psychosis, Bipolar Affective Disorder, Mental Disorders Due to Epilepsy, Mental Retardation Accompanied by Mental DisordersView official trial listing → -
Recruiting NCT NCT06936137
: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)
Not yet reported Ain Shams University 180 participants Est. completion 2026-12-20 1 siteOther conditions: Antipsychotic Induced Weight GainView official trial listing → -
Recruiting NCT NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
Not yet reported Vanda Pharmaceuticals 400 participants Est. completion 2027-11 22 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT06978803
HYEEG Discourse in Psychosis: A Neurobehavioural Study
Douglas Mental Health University Institute 110 participants Est. completion 2026-12-31 1 siteOther conditions: Psychosis, Schizophrenia DisordersView official trial listing → -
Recruiting NCT NCT06997198
Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities
Not yet reported University Hospitals Cleveland Medical Center 25 participants Est. completion 2027-10-01 1 siteOther conditions: Tardive Dyskinesia, Intellectual Disability, Developmental DisabilitiesView official trial listing → -
Recruiting NCT NCT07008235
Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia
Not yet reported, Not yet reported Md. Moktadirul Hoque Shuvo 120 participants Est. completion 2026-06 1 siteOther conditions: Functional DyspepsiaView official trial listing → -
Recruiting NCT NCT07025590
Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)
Not yet reported Guangdong Provincial People's Hospital 106 participants Est. completion 2027-03-31 1 siteCardiovascular disease Other conditions: Depression Anxiety DisorderView official trial listing → -
Recruiting NCT NCT07055204
Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia
Not yet reported University Hospital, Toulouse 120 participants Est. completion 2028-12-31 6 sitesOther conditions: Schizophrenia DisordersView official trial listing → -
Recruiting NCT NCT07085923
Norwegian Mental Illness Heart Health Study
Not yet reported Madeleine Elisabeth Angelsen 70 participants Est. completion 2028-06-30 1 siteMetabolic syndrome Other conditions: Cardio Vascular Disease, Severe Mental Disorder, Schizophrenia and Schizophrenia Spectrum Psychosis, Bipolar Disease Type I, Overweight and/or Obesity, CVD Risk Factors, Severe Mental IllnessView official trial listing → -
Recruiting NCT NCT07109245
Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?
Not yet reported Centre for Addiction and Mental Health 35 participants Est. completion 2028-12 1 siteOther conditions: Brain Insulin Sensitivity, Healthy Controls, CognitionView official trial listing → -
Recruiting NCT NCT07122531
Recovery With Exogenous Ketones and Antipsychotics
Not yet reported Université de Sherbrooke 15 participants Est. completion 2027-08-15 1 siteOther conditions: First Episode PsychosisView official trial listing → -
Recruiting NCT NCT07139171
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Tianjin Anding Hospital 300 participants Est. completion 2025-12-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT07184619
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Not yet reported Newron Pharmaceuticals SPA 400 participants Est. completion 2027-03-31 25 sitesOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Recruiting NCT NCT07244640
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2028-12 1 siteOther conditions: Parkinson's Disease (PD)View official trial listing → -
Recruiting NCT NCT07246044
HD-tDCS for Adolescent Bipolar Depression Targeting S1
Not yet reported Jiangsu Province Nanjing Brain Hospital 100 participants Est. completion 2027-12-31 1 siteOther conditions: Adolescent, Bipolar Depression, tDCS, Primary Somatosensory Cortex, Bipolar Disorder DepressionView official trial listing → -
Recruiting NCT NCT07343193
Deprescribing Antipsychotics: a Multiple Case Study
University Hospital, Strasbourg, France 30 participants Est. completion 2026-09-09 1 siteOther conditions: Psychotic DisorderView official trial listing → -
Recruiting NCT NCT07360665
Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Acting Injectable Antipsychotics
Not yet reported University of Trás-os-Montes and Alto Douro 44 participants Est. completion 2026-11-30 1 siteOther conditions: Psychotic Disorders, Schizophrenia Spectrum Disorders (SSD), Severe Mental IllnessView official trial listing → -
Recruiting NCT NCT07363577
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Not yet reported LB Pharmaceuticals Inc. 456 participants Est. completion 2027-10 13 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT07402928
Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease
Danish Research Centre for Magnetic Resonance 140 participants Est. completion 2027-06-30 1 siteOther conditions: Healthy, Parkinson, Medication AdministrationView official trial listing → -
Recruiting NCT NCT07483294
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Not yet reported Northwell Health 120 participants Est. completion 2030-06-01 1 siteOther conditions: Psychosis; AcuteView official trial listing → -
Recruiting NCT NCT07565428
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
Not yet reported Minerva Neurosciences 380 participants Est. completion 2028-12 13 sitesOther conditions: Negative Symptoms of SchizophreniaView official trial listing → -
Recruiting NCT NCT07606014
No Guts No Glory Probiotics
Not yet reported, Not yet reported University Medical Center Groningen 112 participants Est. completion 2029-05-01 3 sitesOther conditions: Patients Using Olanzapine, Quetiapine, Risperidone or ClozapineView official trial listing → -
Recruiting NCT NCT07696000
The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy
Not yet reported DINA KEUMALA SARI 100 participants Est. completion 2026-10-30 1 siteOther conditions: Schizophrenia / Schizoaffective DisorderView official trial listing → -
Recruiting NCT NCT07795554
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Not yet reported Second Xiangya Hospital of Central South University 60 participants Est. completion 2027-06-01 1 siteOther conditions: Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight GainView official trial listing → -
Recruiting NCT NCT07805980
A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
Not yet reported Second Xiangya Hospital of Central South University 30 participants Est. completion 2027-06-01 1 siteOther conditions: Schizophrenia, Antipsychotic Induced Weight GainView official trial listing → -
Recruiting NCT NCT07817069
Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects
Not yet reported Faculty of Medicine, Sousse 30 participants Est. completion 2028-12 1 siteOther conditions: Treatment Resistant Schizophrenia, Obesity & Overweight, Abdominal ObesityView official trial listing → -
Recruiting NCT NCT07858565
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
Bosnalijek D.D 500 participants Est. completion 2027-05 1 siteOther conditions: Schizophrenia, Bipolar Affective DisorderView official trial listing → -
Recruiting NCT NCT07918222
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
Not yet reported Shanghai Mental Health Center 300 participants Est. completion 2030-12-01 1 siteOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Completed NCT NCT00000371
Trial of D-Cycloserine in Schizophrenia
Not yet reported Massachusetts General Hospital 60 participants Est. completion 2002-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00000373
Treatment of Obsessive-Compulsive Disorder
Not yet reported University of Florida 74 participants Est. completion 2003-07 2 sitesOther conditions: Obsessive-Compulsive DisorderView official trial listing → -
Completed NCT NCT00000374
Treatment for First-Episode Schizophrenia
Not yet reported Northwell Health 125 participants Est. completion 2007-05 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00001656
Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders
Not yet reported National Institute of Mental Health (NIMH) 25 participants Est. completion 2008-06 1 siteOther conditions: Childhood Schizophrenia, Psychotic Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT00014001
CATIE- Schizophrenia Trial
Not yet reported National Institute of Mental Health (NIMH) 1600 participants Est. completion 2004-12 54 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00015548
CATIE-Alzheimer's Disease Trial
Not yet reported National Institute of Mental Health (NIMH) 450 participants Est. completion 2004-10 34 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00018668
Antipsychotic Response in Schizophrenia
Not yet reported US Department of Veterans Affairs Est. completion 2004-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00034762
Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473 participants Est. completion 2003-01Other conditions: Dementia, Alzheimer Disease, Mental DisordersView official trial listing → -
Completed NCT NCT00034775
A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141 participants Est. completion 2002-10Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00044655
Switching Medication to Treat Schizophrenia
Not yet reported Icahn School of Medicine at Mount Sinai 219 participants Est. completion 2009-03Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00044681
A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 258 participants Est. completion 2004-03Other conditions: Depressive Disorder, Depressive Disorder, Major, DepressionView official trial listing → -
Completed NCT NCT00056472
Study of Pharmacotherapy of Psychotic Depression
Not yet reported Weill Medical College of Cornell University 259 participants Est. completion 2008-06 4 sitesOther conditions: Major Depressive Disorder With Psychotic FeaturesView official trial listing → -
Completed NCT NCT00057135
Improving Antipsychotic Adherence Among Patients With Serious Mental Illness
Not yet reported US Department of Veterans Affairs 150 participants Est. completion 2006-09 5 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00057408
A Controlled Study of Olanzapine in Children With Autism
Not yet reported FDA Office of Orphan Products Development 78 participants Est. completion 2005-09 1 siteOther conditions: Autistic DisorderView official trial listing → -
Completed NCT NCT00061802
Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 225 participants Est. completion 2004-02 13 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00065273
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 50 participants Est. completion 2001-06 1 siteOther conditions: Mental Retardation, Developmental Delay DisorderView official trial listing → -
Completed NCT NCT00065286
Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 1999-11 2 sitesOther conditions: AkathisiaView official trial listing → -
Completed NCT NCT00073164
Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
Not yet reported Abbott 400 participants 35 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00073320
Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 88 participants Est. completion 2004-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00074477
Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250 participants Est. completion 2004-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00077727
A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 107 participants Est. completion 2005-02Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00081380
Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
Not yet reported AstraZeneca 710 participants Est. completion 2006-09 94 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00083668
Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 619 participants Est. completion 2005-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00086112
Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 301 participants Est. completion 2005-06Other conditions: Anxiety DisordersView official trial listing → -
Completed NCT NCT00086593
Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia
Not yet reported GlaxoSmithKline 209 participants Est. completion 2005-07 39 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00088751
Treatment Study of Frontotemporal Dementia
National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2009-06-01 1 siteOther conditions: Frontotemporal Lobar DegenerationView official trial listing → -
Completed NCT NCT00096863
The MIND Study: Modifying the INcidence of Delirium
Not yet reported Vanderbilt University 102 participants Est. completion 2007-07 5 sitesOther conditions: Delirium, Cognition DisordersView official trial listing → -
Completed NCT NCT00097942
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
Not yet reported Forest Laboratories 138 participants Est. completion 2005-09 13 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00101634
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 518 participants Est. completion 2006-03Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00107939
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Not yet reported Novartis Pharmaceuticals 453 participants Est. completion 2007-04 22 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00108368
The Effects of Risperidone and Olanzapine on Thinking
Not yet reported US Department of Veterans Affairs Est. completion 2006-03 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00111189
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 414 participants Est. completion 2008-02 55 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00122070
Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder
Not yet reported University of Medicine and Dentistry of New Jersey 15 participants Est. completion 2008-05 1 siteOther conditions: Borderline Personality DisorderView official trial listing → -
Completed NCT NCT00132314
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Not yet reported US Department of Veterans Affairs 382 participants Est. completion 2009-09 19 sitesOther conditions: Schizoaffective Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT00137020
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294 participants Est. completion 2006-04 27 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00140426
A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa
Not yet reported University of Colorado, Denver 41 participants Est. completion 2009-12 1 siteObstructive sleep apneaView official trial listing → -
Status unknown NCT NCT00141947
Bexarotene Treatment in Schizophrenia
Not yet reported Beersheva Mental Health Center 15 participants Est. completion 2006-09 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00144027
Patient-Centered Medication Adherence Intervention for Schizophrenia
Not yet reported US Department of Veterans Affairs 75 participants Est. completion 2009-07 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00148564
Energy Homeostasis Under Treatment With Atypical Antipsychotics
Not yet reported Charite University, Berlin, Germany 40 participants Est. completion 2007-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00149734
Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
Not yet reported University of Colorado, Denver 8 participants Est. completion 2010-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00156637
A Study of Strategies to Improve Schizophrenia Treatment
Not yet reported US Department of Veterans Affairs 106 participants Est. completion 2008-03 4 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00156715
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
Not yet reported Dartmouth-Hitchcock Medical Center 23 participants Est. completion 2008-10 4 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol AbuseView official trial listing → -
Status unknown NCT NCT00157378
Optimization of Acute Treatment in First Episode Schizophrenia
Not yet reported Ludwig-Maximilians - University of Munich 300 participants Est. completion 2004-12 1 siteOther conditions: Schizophrenia, First-EpisodeView official trial listing → -
Completed NCT NCT00159081
One Year Drug Treatment in First-Episode Schizophrenia
Not yet reported Heinrich-Heine University, Duesseldorf 159 participants Est. completion 2005-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00159120
Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia
Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 siteOther conditions: Schizophrenia, PsychosesView official trial listing → -
Completed NCT NCT00159133
Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia
Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 siteOther conditions: Schizophrenia, PsychosesView official trial listing → -
Terminated NCT NCT00159757
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 150 participants Est. completion 2005-02 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00159770
Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290 participants Est. completion 2004-09 43 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT00161018
New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia
Not yet reported University of Maryland, Baltimore 150 participants Est. completion 2004-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00161031
Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia
Not yet reported University of Maryland, Baltimore 30 participants Est. completion 2006-12 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00167154
Risperidone and Suicidality in Major Depressive Disorder
Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2008-08 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT00167310
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
Not yet reported University of Pittsburgh 57 participants Est. completion 2015-12 1 siteCardiovascular disease Other conditions: Schizophrenia, Schizoaffective Disorder, Major Depression, Bipolar DisorderView official trial listing → -
Completed NCT NCT00167934
Determining Metabolic Effects of Valproate and Antipsychotic Therapy
Not yet reported Washington University School of Medicine 164 participants Est. completion 2008-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00169026
Alcoholism and Schizophrenia: Effects of Clozapine
Not yet reported Dartmouth-Hitchcock Medical Center 64 participants Est. completion 2004-01 1 siteOther conditions: Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol AbuseView official trial listing → -
Completed NCT NCT00169702
The Effect of a Weight Management Program During Treatment With Olanzapine
Not yet reported Heinrich-Heine University, Duesseldorf 100 participants Est. completion 2007-07 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00169988
Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
Not yet reported Northwell Health 8 participants Est. completion 2007-04 1 siteOther conditions: Prodromal Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00174200
Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
Not yet reported Pfizer 20 participants Est. completion 2006-05 3 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00175955
Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Not yet reported UCB Pharma 70 participants Est. completion 2005-12 7 sitesOther conditions: Dyskinesia, Medication-inducedView official trial listing → -
Completed NCT NCT00176202
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
Not yet reported University of Illinois Chicago 65 participants Est. completion 2008-01 3 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00177164
Risperdal Consta for Bipolar Disorder
Not yet reported University of Pittsburgh 50 participants Est. completion 2009-12 4 sitesOther conditions: Bipolar I DisorderView official trial listing → -
Completed NCT NCT00178932
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors
Not yet reported Northwestern University 37 participants Est. completion 2024-05-16 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major DepressionView official trial listing → -
Completed NCT NCT00178958
Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia
Not yet reported Northwestern University 70 participants Est. completion 2006-06Other conditions: Schizophrenia, Schizoaffective, Bipolar DisorderView official trial listing → -
Completed NCT NCT00179062
Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
Not yet reported Vanderbilt University 300 participants Est. completion 2007-06 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Depressive Disorder, Major, Bipolar DisorderView official trial listing → -
Active, not recruiting NCT NCT00179465
Treating Schizophrenia by Correcting Abnormal Brain Development
Not yet reported Beth Israel Deaconess Medical Center 36 participants Est. completion 2026-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00182494
Diabetes Prevention Program in Schizophrenia [DPPS]
Not yet reported Hamilton Health Sciences Corporation 200 participants Est. completion 2009-01 1 siteOther conditions: Diabetes Mellitus, SchizophreniaView official trial listing → -
Completed NCT NCT00183625
Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients
Not yet reported University of California, Los Angeles 107 participants Est. completion 2006-09 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00188942
A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
Not yet reported University Health Network, Toronto 42 participants Est. completion 2009-06 2 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00191555
Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
Not yet reported Eli Lilly and Company 360 participants Est. completion 2006-05 62 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00191828
A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme
Not yet reported Eli Lilly and Company 60 participants Est. completion 2005-08 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00194038
Aripiprazole in Late Life Bipolar Disorder
Not yet reported University Hospitals Cleveland Medical Center 20 participants Est. completion 2006-06Other conditions: Bipolar DisorderView official trial listing → -
Status unknown NCT NCT00197834
Study of Depakote for Behavioral and Psychological Symptoms in Dementia
Not yet reported Hearthstone Alzheimer Care 20 participants 1 siteOther conditions: DementiaView official trial listing → -
Completed NCT NCT00198107
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
Not yet reported Indiana University 81 participants Est. completion 2011-09 1 siteOther conditions: Autistic DisorderView official trial listing → -
Status unknown NCT NCT00201292
Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)
National Health Research Institutes, Taiwan 1350 participants Est. completion 2008-10 3 sitesMetabolic syndrome Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00202280
Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication
Not yet reported, Not yet reported Melbourne Health 120 participants Est. completion 2009-06 1 siteOther conditions: First Episode PsychosisView official trial listing → -
Completed NCT NCT00202293
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
Not yet reported Melbourne Health 83 participants Est. completion 2015-11-01 1 siteOther conditions: Bipolar Disorder, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00205660
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
Not yet reported Washington University School of Medicine 51 participants Est. completion 2009-08 1 siteType 2 diabetes Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00205699
Metabolic Effects of Antipsychotics in Children
Not yet reported Washington University School of Medicine 144 participants Est. completion 2011-07 1 siteOther conditions: Aggression, Attention Deficit-Hyperactivity, Oppositional Defiant Disorder, Pervasive Development Disorders, Bipolar DisorderView official trial listing → -
Completed NCT NCT00206570
Clinical Estradiol Trial in Women With Schizophrenia
Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00206960
Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia
Not yet reported Birte Glenthoj 56 participants Est. completion 2010-09 6 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00207064
Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia
Not yet reported Birte Glenthoj 46 participants Est. completion 2008-09 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00208533
Aripiprazole in Children With Autism: A Pilot Study
Not yet reported Drexel University College of Medicine 11 participants Est. completion 2011-11-16 1 siteOther conditions: AutismView official trial listing → -
Completed NCT NCT00210548
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 366 participants Est. completion 2006-06Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00210717
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 748 participants Est. completion 2007-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00210769
A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203 participants Est. completion 2005-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00215150
Geodon for the Treatment of Refractory Social Anxiety Disorder
Not yet reported Duke University 51 participants Est. completion 2009-07 2 sitesOther conditions: Social Anxiety DisorderView official trial listing → -
Completed NCT NCT00215241
Risperidone Augmentation for PTSD
Not yet reported, Not yet reported Duke University 80 participants Est. completion 2006-07 2 sitesOther conditions: Post-Traumatic Stress DisorderView official trial listing → -
Completed NCT NCT00215254
Quetiapine in Social Anxiety Disorder
Not yet reported, Not yet reported Duke University 15 participants Est. completion 2006-02 1 siteOther conditions: Social Anxiety DisorderView official trial listing → -
Completed NCT NCT00216476
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Janssen-Cilag International NV 753 participants Est. completion 2007-11 96 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00216580
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
Not yet reported Janssen Pharmaceutica N.V., Belgium 50 participants Est. completion 2006-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00216632
A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
Not yet reported Janssen Pharmaceutica N.V., Belgium 99 participants Est. completion 2007-07Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00216671
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode
Not yet reported Janssen Pharmaceutica N.V., Belgium 220 participants Est. completion 2009-12 31 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00222807
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus
University of Pittsburgh 200 participants Est. completion 2016-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Delusional DisorderView official trial listing → -
Completed NCT NCT00222833
The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
Not yet reported University of Pittsburgh 30 participants Est. completion 2005-12 1 siteCardiovascular disease Other conditions: Overweight, HyperlipidemiaView official trial listing → -
Completed NCT NCT00223522
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?
The University of Texas Health Science Center at San Antonio 50 participants Est. completion 2005-03 1 siteOther conditions: Schizophrenia, SchizoaffectiveView official trial listing → -
Completed NCT NCT00224276
Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics
Yale University 100 participantsOther conditions: Schizophrenia, Bipolar Disorder, Diabetes MellitusView official trial listing → -
Completed NCT NCT00224822
The Effects of Aripiprazole on Patients With Metabolic Syndrome
Not yet reported New Mexico VA Healthcare System 27 participants Est. completion 2007-03 1 siteMetabolic syndrome Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00230893
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
Tuscaloosa Research & Education Advancement Corporation 99 participants Est. completion 2005-09 1 siteOther conditions: PTSD, Post-Traumatic Stress DisorderView official trial listing → -
Completed NCT NCT00231894
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
Not yet reported Nathan Kline Institute for Psychiatric Research 56 participants Est. completion 2010-01 1 siteOther conditions: Diabetes, Schizophrenia, Insulin Resistance, Cognitive ImpairmentView official trial listing → -
Completed NCT NCT00232336
Quetiapine for Cocaine Use and Cravings
Not yet reported Seattle Institute for Biomedical and Clinical Research 42 participants Est. completion 2006-01 1 siteSubstance use disorder Other conditions: Cocaine-Related DisordersView official trial listing → -
Withdrawn NCT NCT00233467
Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
Tuscaloosa Research & Education Advancement Corporation Est. completion 2005-09-30 1 siteOther conditions: PTSD, Posttraumatic Stress DisorderView official trial listing → -
Completed NCT NCT00234377
Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
Not yet reported AstraZeneca 550 participants Est. completion 2006-05 27 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00236457
A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629 participants Est. completion 2002-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00236587
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100 participants Est. completion 2004-02Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00237861
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia
Not yet reported Yale UniversityOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00240708
A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
Not yet reported Janssen Pharmaceutical K.K. 205 participants Est. completion 2006-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00245206
Side Effects of Newer Antipsychotics in Older Adults
Not yet reported Veterans Medical Research Foundation 406 participants Est. completion 2010-10 1 siteOther conditions: Schizophrenia, Alzheimer's Disease, DementiaView official trial listing → -
Completed NCT NCT00246246
A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder
Not yet reported Janssen-Ortho Inc., Canada 48 participants Est. completion 2006-04Other conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00246259
A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis
Not yet reported Janssen-Ortho Inc., Canada 77 participants Est. completion 2008-12 11 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT00246285
A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 381 participants Est. completion 2006-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00249119
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia
Not yet reported Janssen, LP 1579 participants Est. completion 1991-12Other conditions: Schizophrenia, Psychotic DisorderView official trial listing → -
Completed NCT NCT00249132
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia
Not yet reported Janssen, LP 523 participants Est. completion 1991-07Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00249171
A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients
Not yet reported Janssen Pharmaceutica N.V., Belgium 226 participants Est. completion 2003-02Other conditions: Schizophrenia, Psychotic Disorders, Emergency TreatmentView official trial listing → -
Completed NCT NCT00249223
A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
Not yet reported Janssen Pharmaceutica N.V., Belgium 641 participants Est. completion 2000-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00249236
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291 participants Est. completion 2001-12Other conditions: Bipolar Disorder, Manic EpisodeView official trial listing → -
Completed NCT NCT00250367
A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
Not yet reported Janssen Pharmaceutica N.V., Belgium 151 participants Est. completion 1999-11Other conditions: Bipolar Disorder, Manic DisorderView official trial listing → -
Completed NCT NCT00253136
A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
Not yet reported Janssen, LP 458 participants Est. completion 2000-12Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00253149
A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 158 participants Est. completion 1999-04Other conditions: Bipolar Disorders, Manic DisorderView official trial listing → -
Completed NCT NCT00253162
A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 439 participants Est. completion 2002-09Other conditions: Bipolar Disorders, Manic DisorderView official trial listing → -
Completed NCT NCT00254202
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
Not yet reported Vanda Pharmaceuticals 593 participants Est. completion 2007-03-21 42 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00255879
Movement Disorders Caused by Antipsychotic Drugs in Older Patients
Not yet reported University of California, San Diego 250 participants Est. completion 2004-08 1 siteOther conditions: Dyskinesia, Drug-InducedView official trial listing → -
Terminated NCT NCT00256997
A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
Not yet reported Janssen-Ortho Inc., Canada 167 participants Est. completion 2009-04 44 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00257075
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267 participants Est. completion 2002-05Other conditions: Bipolar Disorders, Manic EpisodeView official trial listing → -
Completed NCT NCT00264069
ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry
Janssen-Cilag, S.A. 2622 participants Est. completion 2006-06Other conditions: Schizophrenia, Bipolar Disorder, Depression, Personality DisorderView official trial listing → -
Terminated NCT NCT00272025
Treatment Resistant Bipolar Depression
Not yet reported Queen's University 1 participants Est. completion 2010-01 1 siteOther conditions: Bipolar DepressionView official trial listing → -
Completed NCT NCT00272597
Risperidone LA Heathcare Resource Study
Not yet reported University of British Columbia 30 participants Est. completion 2010-10 1 siteOther conditions: Psychosis, SchizophreniaView official trial listing → -
Terminated NCT NCT00279409
Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
Not yet reported New York State Psychiatric Institute 10 participants Est. completion 2009-02 1 siteOther conditions: Attention Deficit Hyperactivity DisorderView official trial listing → -
Completed NCT NCT00283517
A Registry of Treatment Adherence for Patients With Schizophrenia
Janssen-Cilag, S.A. 2046 participants Est. completion 2006-05Other conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Terminated NCT NCT00287027
Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
National Alliance on Mental Illness New Hampshire 60 participants Est. completion 2006-12 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Terminated NCT NCT00287742
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
Not yet reported Janssen Pharmaceutical K.K. 33 participants Est. completion 2003-03Other conditions: Alzheimer's Disease, DementiaView official trial listing → -
Terminated NCT NCT00288353
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Not yet reported Northwestern University 48 participants Est. completion 2008-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
Not yet reported Northwestern University 49 participants Est. completion 2008-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00290121
Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics
Not yet reported Université de Montréal 25 participants Est. completion 2008-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00292370
Quetiapine Augmentation for Treatment-resistant PTSD
Not yet reported VA Office of Research and Development 124 participants Est. completion 2009-05 3 sitesOther conditions: Combat Disorders, Stress Disorders, Post-TraumaticView official trial listing → -
Completed NCT NCT00294008
A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)
Janssen Korea, Ltd., Korea 230 participants Est. completion 2009-06Other conditions: Schizophrenia, Tranquilizing Agents, Mental Disorders, Therapeutic Uses, Physiological Effects of Drugs, Psychotropic Drugs, Antipsychotic AgentsView official trial listing → -
Completed NCT NCT00297388
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40 participants Est. completion 2004-09Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00297739
Risperidone Augmentation for Treatment-Resistant Aggression in ADHD
Not yet reported Armenteros, Jorge L., M.D., P.A. 25 participants Est. completion 2005-04 1 siteOther conditions: AggressionView official trial listing → -
Completed NCT NCT00304616
SWitching to Abilify Trial (SWAT)
Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 500 participants Est. completion 2007-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00306475
Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
Not yet reported Northwestern University 60 participants Est. completion 2008-04 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00309413
A Clinical Trial on the Antipsychotic Properties of Cannabidiol
Not yet reported University of Cologne 29 participants Est. completion 2008-07 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT00309452
Specialized Treatment Early in Psychosis (STEP)
Not yet reported Yale University 120 participants Est. completion 2013-08 1 siteOther conditions: Schizophrenia and Disorders With Psychotic FeaturesView official trial listing → -
Terminated NCT NCT00310661
Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Not yet reported Centre for Addiction and Mental Health 60 participants Est. completion 2008-03 2 sitesOther conditions: Neuroleptic-induced Tardive DyskinesiaView official trial listing → -
Completed NCT NCT00312598
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
University of North Carolina, Chapel Hill 30 participants Est. completion 2010-04Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Mood DisordersView official trial listing → -
Terminated NCT NCT00314613
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
Not yet reported Duke University 30 participants 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00314639
Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia
Not yet reported, Not yet reported Laval University 30 participants 1 siteOther conditions: Schizophrenia and Schizophrenia Spectrum PsychosisView official trial listing → -
Completed NCT NCT00328952
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
Seoul National University Hospital 40 participants Est. completion 2008-08 1 siteOther conditions: Schizophrenia, HallucinationsView official trial listing → -
Status unknown NCT NCT00330226
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
Seoul National University Hospital 500 participants Est. completion 2012-12 1 siteOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT00330551
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
Not yet reported University of California, Los Angeles 126 participants Est. completion 2012-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00330863
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Not yet reported Northwell Health 357 participants Est. completion 2011-01 8 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00331825
Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism
Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70 participants Est. completion 2003-07 1 siteOther conditions: Schizophrenia, Extrapyramidal SyndromeView official trial listing → -
Completed NCT NCT00332098
Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents
Not yet reported University of California, Los Angeles 145 participants Est. completion 2012-07 3 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00333177
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
Not yet reported University of California, Los Angeles 92 participants Est. completion 2013-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00334035
Antipsychotic Therapy and First Episode
Not yet reported The University of Hong Kong 169 participants Est. completion 2007-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00334126
Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 399 participants Est. completion 2007-09Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00337662
Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia
Not yet reported Eli Lilly and Company 628 participants Est. completion 2007-12 34 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00344500
Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications
Not yet reported VA Office of Research and Development 122 participants Est. completion 2009-09 1 siteOther conditions: Diabetes, Obesity, Weight GainView official trial listing → -
Completed NCT NCT00347425
Switch Study of Existing Atypical Antipsychotics to Bifeprunox
Not yet reported Solvay Pharmaceuticals 286 participants Est. completion 2008-02 122 sitesOther conditions: Schizophrenia and Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00357006
A Definitive Estrogen Patch Study (ADEPT)
Not yet reported The Alfred 180 participants Est. completion 2013-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)View official trial listing → -
Completed NCT NCT00361166
Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone
Not yet reported ACADIA Pharmaceuticals Inc. 400 participants Est. completion 2007-03 17 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00362804
Tetrabenazine for Partial Responders
Not yet reported Centre for Addiction and Mental Health 41 participants Est. completion 2006-01 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00363181
Side Effects of Antipsychotic Medications
Stanford University 76 participants Est. completion 2011-12 1 siteMetabolic syndrome Other conditions: Insulin Resistance, Schizophrenia and Disorders With Psychotic Features, Mood Disorders, Psychotic DisordersView official trial listing → -
Completed NCT NCT00373672
Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Northwestern University 58 participants Est. completion 2010-01 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT00374543
Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
Not yet reported Massachusetts General Hospital 3 participants Est. completion 2008-11 1 siteOther conditions: Generalized Anxiety Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00378092
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
Not yet reported Janssen Cilag N.V./S.A. 33 participants Est. completion 2010-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00378183
A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.
Not yet reported Janssen, LP 120 participants Est. completion 2002-05Other conditions: Schizoaffective Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT00389493
Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder
Not yet reported New York State Psychiatric Institute 100 participants Est. completion 2012-12 2 sitesOther conditions: Obsessive-Compulsive DisorderView official trial listing → -
Completed NCT NCT00391261
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
Not yet reported Cambridge Health Alliance 11 participants Est. completion 2007-10 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar Disorder, Autism Spectrum DisordersView official trial listing → -
Completed NCT NCT00392743
A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients
GlaxoSmithKline 60 participants Est. completion 2007-05 7 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00395915
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
Not yet reported Universita di Verona 106 participants Est. completion 2009-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00397033
Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 316 participants Est. completion 2008-02Other conditions: Schizoaffective Disorder, Psychotic DisorderView official trial listing → -
Completed NCT NCT00399334
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders
Janssen-Cilag, S.A. 1607 participants Est. completion 2005-12Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00399776
Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy
Creighton University 60 participants Est. completion 2009-09 1 siteOther conditions: Adolescent DepressionView official trial listing → -
Completed NCT NCT00401089
Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia
Not yet reported, Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60 participants Est. completion 2007-10 4 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Tardive Dyskinesia, Insulin Resistance, ObesityView official trial listing → -
Completed NCT NCT00406315
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 255 participants Est. completion 2009-03 40 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00406718
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
Not yet reported The University of Texas Health Science Center at San Antonio 197 participants Est. completion 2013-07 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00412373
Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 307 participants Est. completion 2008-06 44 sitesOther conditions: Schizoaffective Disorder, Psychotic DisorderView official trial listing → -
Completed NCT NCT00417482
Antipsychotic Discontinuation in Alzheimer's Disease
Not yet reported New York State Psychiatric Institute 180 participants Est. completion 2011-04 7 sitesOther conditions: Alzheimer Disease, Psychotic Disorders, Agitation, AggressionView official trial listing → -
Terminated NCT NCT00418873
Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward
Not yet reported Astellas Pharma Inc 39 participants Est. completion 2009-12 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00419146
Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants
Not yet reported, Not yet reported University Hospital, Aker 99 participants Est. completion 2004-04 1 siteOther conditions: Schizophrenia, Schizophreniform Disorders, Schizoaffective Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT00420823
A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment
Not yet reported, Not yet reported Melbourne Health 121 participants Est. completion 2010-12 2 sitesOther conditions: Psychotic DisordersView official trial listing → -
Completed NCT NCT00423878
Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
Not yet reported National Institute of Mental Health (NIMH) 215 participants Est. completion 2010-03 28 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Withdrawn NCT NCT00425815
Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
Not yet reported University of California, Los Angeles Est. completion 2009-04 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00431574
Antipsychotic Medication Extended Dosing Study
Not yet reported Centre for Addiction and Mental Health 120 participants Est. completion 2007-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00433121
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
Not yet reported Sykehuset Innlandet HF 24 participants Est. completion 2007-08 1 siteOther conditions: DementiaView official trial listing → -
Completed NCT NCT00434876
The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence
Not yet reported Subhajit Chakravorty 22 participants Est. completion 2009-12 1 siteOther conditions: Alcoholism, Sleep Initiation and Maintenance DisordersView official trial listing → -
Terminated NCT NCT00439634
Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia
Not yet reported Sanofi 873 participants Est. completion 2009-09 2 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT00440843
Zyprexa and Task Engagement in Schizophrenia
Not yet reported VA Connecticut Healthcare System Est. completion 2012-06 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00448630
An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 328 participants Est. completion 2008-07-30 47 sitesMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00451399
Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain
Not yet reported Central South University 128 participants Est. completion 2006-12 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00456976
Efficacy of Selegiline in Negative Symptoms of Schizophrenia
Not yet reported Tabriz University 70 participants Est. completion 2007-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00457197
Quetiapine for Bipolar Disorder and Alcohol Dependence
Not yet reported University of Texas Southwestern Medical Center 90 participants Est. completion 2011-07 1 siteAlcohol use disorder Other conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00458211
Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics
Not yet reported Bronx Psychiatric Center 40 participants Est. completion 2008-04 2 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00460512
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia
Not yet reported Janssen-Cilag International NV 1814 participants Est. completion 2020-03-04 231 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00469664
Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
Not yet reported Research Foundation for Mental Hygiene, Inc. 50 participants Est. completion 2008-12 3 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Cognitive ImpairmentView official trial listing → -
Completed NCT NCT00474227
Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness
Not yet reported Lev-Hasharon Mental Healtlh Center 50 participants Est. completion 2007-10 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00480168
A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50 participants Est. completion 2012-08-31 2 sitesOther conditions: Adverse EffectsView official trial listing → -
Completed NCT NCT00485498
Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics
Not yet reported Eli Lilly and Company 122 participants Est. completion 2003-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00488319
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
Not yet reported Janssen Research & Development, LLC 400 participants Est. completion 2012-07 53 sitesOther conditions: Schizophrenia, Schizophrenic Disorders, Psychotic Disorders, Dementia PraecoxView official trial listing → -
Terminated NCT NCT00488891
The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
Ortho-McNeil Janssen Scientific Affairs, LLC 43 participants Est. completion 2007-10Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00493233
Antipsychotic Polypharmacy in Schizophrenia
Not yet reported Centre for Addiction and Mental Health 100 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00495352
The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia
Not yet reported Yu-Li Hospital 360 participants Est. completion 2008-12 1 siteOther conditions: Tobacco Dependence, SchizophreniaView official trial listing → -
Completed NCT NCT00498550
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual
Not yet reported Dartmouth-Hitchcock Medical Center 31 participants Est. completion 2009-03 4 sitesOther conditions: Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Cannabis AbuseView official trial listing → -
Terminated NCT NCT00506909
Oxytocin Add on Study for Stable Schizophrenic Patients
Not yet reported David Feifel 21 participants Est. completion 2014-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00508157
A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 125 participants Est. completion 2009-03-01 30 sitesMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00514449
Systematic Evaluation of Antiviral Medication in Schizophrenia
Not yet reported Konasale Prasad 31 participants Est. completion 2016-09 2 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00515723
Glucose and Lipid Metabolism on Antipsychotic Medication
Not yet reported Washington University School of Medicine 96 participants Est. completion 2008-12 2 sitesType 2 diabetes Other conditions: Schizophrenia, Schizoaffective Disorder, HyperglycemiaView official trial listing → -
Completed NCT NCT00517387
The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression
Not yet reported University of British Columbia 64 participants Est. completion 2010-09 1 siteOther conditions: Unipolar DepressionView official trial listing → -
Completed NCT NCT00518323
A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201 participants Est. completion 2009-03 34 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00523445
The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia
Not yet reported Inje University 120 participants Est. completion 2009-07 5 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00526877
An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
Not yet reported Johnson & Johnson Taiwan Ltd 31 participants Est. completion 2009-01-31 1 siteOther conditions: Schizophrenia, Schizoaffective DisordersView official trial listing → -
Completed NCT NCT00528359
β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 36 participants Est. completion 2007-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00533455
Gabapentin for the Treatment of Neuroleptic-Induced Tremor
Not yet reported Minneapolis Veterans Affairs Medical Center 40 participants Est. completion 2007-08 1 siteOther conditions: Neuroleptic-Induced TremorView official trial listing → -
Completed NCT NCT00534222
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
AstraZeneca 387 participants Est. completion 2007-12 6 sitesOther conditions: Mania, SchizophreniaView official trial listing → -
Withdrawn NCT NCT00534898
Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients
Not yet reported Beersheva Mental Health Center 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, CognitionView official trial listing → -
Completed NCT NCT00535145
Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease
Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC 121 participants Est. completion 2009-02 21 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT00535574
Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia
Not yet reported Beersheva Mental Health Center 90 participants Est. completion 2011-05 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00536783
Schizophrenia Sensory Gating Deficit With Quetiapine
New Mexico VA Healthcare System 20 participants Est. completion 2006-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00538122
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment
Vanderbilt University 12 participants Est. completion 2008-09 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00538642
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2011-11 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00541398
Antipsychotic Polypharmacy: Prevalence, Background and Consequences
Not yet reported Glostrup University Hospital, Copenhagen 222 participants Est. completion 2009-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00541554
Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
Not yet reported Genovate Biotechnology Co., Ltd., Est. completion 2009-02Other conditions: Hyperprolactinemia, Weight Gain, DyslipidemiaView official trial listing → -
Completed NCT NCT00543088
Effectiveness of Anti-Psychotic in GPs Setting
AstraZeneca 250 participants Est. completion 2008-06 57 sitesOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT00545467
Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents
Not yet reported National Taiwan University Hospital 79 participants Est. completion 2009-07 1 siteOther conditions: DSM-IV Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00552500
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Not yet reported Washington University School of Medicine 120 participants Est. completion 2005-12 1 siteOther conditions: Insulin Resistance, Body CompositionView official trial listing → -
Completed NCT NCT00555412
Staccato Loxapine Multidose PK
Not yet reported Alexza Pharmaceuticals, Inc. 40 participants Est. completion 2007-12 1 siteOther conditions: Volunteers on Chronic, Stable Antipsychotic RegimensView official trial listing → -
Completed NCT NCT00556140
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
Not yet reported Massachusetts General Hospital 16 participants Est. completion 2008-01 1 siteOther conditions: Psychotic DepressionView official trial listing → -
Completed NCT NCT00561587
Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40 participants Est. completion 2010-02 1 siteAlcohol use disorder Other conditions: Alcohol Relapse Prevention, Alcoholism, Alcohol Consumption, Alcohol AbuseView official trial listing → -
Status unknown NCT NCT00563017
Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
Not yet reported Hospital Authority, Hong Kong 30 participants Est. completion 2005-11 1 siteOther conditions: Schizophrenia, Catatonic, Schizophrenia, Disorganized, Schizophrenia, Paranoid, Schizophrenia, Psychotic DisordersView official trial listing → -
Status unknown NCT NCT00567099
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
Not yet reported New Mexico VA Healthcare System 20 participants Est. completion 2008-09 1 siteOther conditions: Schizophrenia, Sensory GatingView official trial listing → -
Withdrawn NCT NCT00568672
Optimal Duration of Olanzapine Add-on Therapy in Major Depression
Not yet reported Charite University, Berlin, Germany Est. completion 2008-04 1 siteOther conditions: Relapse Rate of a Major Depressive Episode, Safety of Olanzapine in Subjects With Major DepressionView official trial listing → -
Status unknown NCT NCT00569504
Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics
Seoul National Hospital 1000 participants Est. completion 2009-09 1 siteMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00569517
Cognitive Behavioral Therapy for Obesity
Not yet reported US Department of Veterans Affairs 32 participants Est. completion 2009-03 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT00569764
Effect on Metabolic Parameters of Abilify in SPR
Seoul National Hospital 100 participants Est. completion 2009-10 2 sitesMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00576732
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 96 participants Est. completion 2010-03 20 sitesOther conditions: Autistic Disorder, AutismView official trial listing → -
Completed NCT NCT00585273
Antipsychotics and Blood Vessel Function
Jess G. Fiedorowicz 44 participants Est. completion 2014-12 1 siteOther conditions: Bipolar Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT00589914
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1221 participants Est. completion 2009-06 82 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00590577
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 652 participants Est. completion 2008-03 66 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00594269
Dementia Antipsychotics And Antidepressants Discontinuation Study
Not yet reported Sykehuset Innlandet HF 149 participants Est. completion 2010-12 8 sitesOther conditions: DementiaView official trial listing → -
Completed NCT NCT00595504
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
Not yet reported Massachusetts General Hospital 25 participants Est. completion 2010-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisordersView official trial listing → -
Completed NCT NCT00597168
Quality of Life in Schizophrenic Patients
AstraZeneca 124 participants Est. completion 2009-10 45 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00604760
Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia
Not yet reported Memory Pharmaceuticals 160 participants 44 sitesOther conditions: Cognitive Impairment Associated With SchizophreniaView official trial listing → -
Completed NCT NCT00616798
A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
Not yet reported Hoffmann-La Roche 323 participants Est. completion 2010-02 73 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00617058
Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
Not yet reported University of North Carolina, Chapel Hill 1 participants Est. completion 2010-09 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00617240
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
Not yet reported University of North Carolina, Chapel Hill 9 participants Est. completion 2012-10 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00621998
Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60 participants Est. completion 2004-06 1 siteOther conditions: Neuroleptic-Induced Tardive DyskinesiaView official trial listing → -
Completed NCT NCT00625170
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans
Not yet reported Leiden University Medical Center 11 participants Est. completion 2004-12 1 siteOther conditions: Insulin Resistance, DyslipidemiaView official trial listing → -
Completed NCT NCT00627510
Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission
Medical University Innsbruck 161 participants Est. completion 2007-12 1 siteOther conditions: Depression, Affective Disorders, PsychoticView official trial listing → -
Status unknown NCT NCT00627757
Antipsychotic Medicine and Metabolic Syndrome
Glostrup University Hospital, Copenhagen 100 participants Est. completion 2010-12 2 sitesMetabolic syndromeView official trial listing → -
Completed NCT NCT00628290
Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
Not yet reported University of Cologne 42 participants Est. completion 2008-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00632645
Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2017-04-28 1 siteOther conditions: Huntington DiseaseView official trial listing → -
Suspended NCT NCT00636753
Antipsychotics and Metabolic Syndrome
Glostrup University Hospital, Copenhagen 60 participants 2 sitesMetabolic syndromeView official trial listing → -
Completed NCT NCT00636896
Effects of Modafinil on Olanzapine Weight Gain
Not yet reported Neuropsychiatric Research Institute, Fargo, North Dakota 50 participants Est. completion 2007-08 1 siteOther conditions: Weight GainView official trial listing → -
Completed NCT NCT00637234
Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia
Not yet reported, Not yet reported University of Cologne 54 participants Est. completion 2008-07 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00640562
Quetiapine Extended Release Depression Symptoms
Not yet reported AstraZeneca 216 participants Est. completion 2010-02 21 sitesOther conditions: Schizophrenia, DepressionView official trial listing → -
Completed NCT NCT00643123
Allopurinol Add-on Treatment for Refractory Mania
Not yet reported Cedars-Sinai Medical Center 40 participants Est. completion 2010-06 1 siteOther conditions: Bipolar Disorder, Mixed Mania, Treatment-Resistant ManiaView official trial listing → -
Status unknown NCT NCT00645580
Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function
Not yet reported Sha'ar Menashe Mental Health Center 15 participants Est. completion 2009-04 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00649064
A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46 participants Est. completion 2004-09 3 sitesOther conditions: Schizoaffective Disorder, SchizophreniaView official trial listing → -
Terminated NCT NCT00649220
Memantine and Antipsychotics Use
Not yet reported Merz Pharmaceuticals GmbH 19 participants Est. completion 2009-06 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00649844
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 147 participants Est. completion 2004-09 22 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00654576
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
Not yet reported Central South University 1400 participants Est. completion 2007-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00658645
Efficacy of Bifeprunox in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 227 participants Est. completion 2009-11 38 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00659919
Treatment of Neuroleptic Induced Acute Akathisia With Trazodone
Not yet reported BeerYaakov Mental Health Center 13 participants Est. completion 2003-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00665444
Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
Not yet reported University of Pittsburgh 3 participants Est. completion 2009-08 1 siteMetabolic syndrome Other conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00677898
A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)
Not yet reported US Department of Veterans Affairs 239 participants Est. completion 2013-06 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Terminated NCT NCT00681668
Quetiapine in Postpartum Depression
Not yet reported AstraZeneca 5 participants Est. completion 2008-10 1 siteOther conditions: Postpartum Depressive DisorderView official trial listing → -
Completed NCT NCT00682448
Metformin for the Prevention of the Metabolic Side-effects of Zyprexa
Not yet reported Rush University Medical Center 25 participants Est. completion 2011-08 1 siteOther conditions: Metabolic ComplicationsView official trial listing → -
Completed NCT NCT00685334
Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
Not yet reported New York State Psychiatric Institute 22 participants Est. completion 2006-09 2 sitesOther conditions: Eating DisordersView official trial listing → -
Terminated NCT NCT00686699
Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)
Not yet reported Merck Sharp & Dohme LLC 11 participants Est. completion 2008-03-06Other conditions: Akathisia, Drug-Induced, Dyskinesia, Drug-Induced, Parkinsonian DisordersView official trial listing → -
Status unknown NCT NCT00686946
The National Register of Antipsychotic Medication in Pregnancy (NRAMP)
The Alfred 500 participants Est. completion 2025-12 1 siteOther conditions: Pregnancy, Mental DisordersView official trial listing → -
Completed NCT NCT00689325
Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics
AstraZeneca 158 participants Est. completion 2010-01 37 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00690274
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
Not yet reported University of Texas Southwestern Medical Center 52 participants Est. completion 2011-10 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00690365
Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia
AstraZeneca 576 participants Est. completion 2008-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00691353
Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers
AstraZeneca 540 participants Est. completion 2008-07 20 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00692133
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment
AstraZeneca 250 participants Est. completion 2008-08 32 sitesOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT00692185
Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa
Not yet reported New York State Psychiatric Institute 23 participants Est. completion 2010-09 1 siteOther conditions: Eating DisordersView official trial listing → -
Terminated NCT NCT00693472
Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)
Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2009-01-09Other conditions: Akathisia, Drug-Induced, Antipsychotic Agents, Movement DisordersView official trial listing → -
Completed NCT NCT00696813
Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics
Janssen-Cilag International NV 3064 participants Est. completion 2011-01 84 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00698295
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
Seoul National University Hospital 60 participants Est. completion 2010-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00699946
Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery
Not yet reported The New England Baptist Hospital 495 participants Est. completion 2007-10 1 siteOther conditions: DeliriumView official trial listing → -
Terminated NCT NCT00701753
A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
TheraGenetics Limited 24 participants Est. completion 2009-03 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT00704509
Efficacy of Bifeprunox in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 346 participants Est. completion 2009-11 45 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00707382
Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment
Not yet reported Gesche Jurgens 311 participants Est. completion 2011-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00709202
Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain
Not yet reported Nathan Kline Institute for Psychiatric Research 48 participants Est. completion 2016-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar I Disorder, Bipolar II, Bipolar NOS(Not Otherwise Specified), Psychotic Disorder Not Otherwise Specified, Autism Spectrum DisorderView official trial listing → -
Completed NCT NCT00709345
Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks
Not yet reported, Not yet reported Medical College of Wisconsin 333 participants Est. completion 2011-07Other conditions: Mental IllnessView official trial listing → -
Terminated NCT NCT00712270
Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
Not yet reported Kettering Health Network 21 participants Est. completion 2010-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00712660
Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia
Not yet reported Prague Psychiatric Center 146 participants Est. completion 2012-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00715377
Anticholinergic Burden in Schizophrenia
Not yet reported Centre for Addiction and Mental Health 2 participants Est. completion 2011-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT00716755
Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.
Not yet reported Centre for Addiction and Mental Health 45 participants Est. completion 2015-08 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional Disorder, Psychotic DisorderView official trial listing → -
Completed NCT NCT00725075
Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)
Not yet reported Merck Sharp & Dohme LLC 215 participants Est. completion 2008-10-24Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00733668
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
Not yet reported AstraZeneca Est. completion 2007-11 4 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT00740259
Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol
Not yet reported Ambulatório de Bipolaridade 70 participants Est. completion 2007-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00741026
A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers
Not yet reported Milton S. Hershey Medical Center 15 participants Est. completion 2011-05 1 siteOther conditions: Insulin Resistance, Diabetes MellitusView official trial listing → -
Completed NCT NCT00745966
Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder
AstraZeneca 1000 participants 2 sitesOther conditions: Naturalistic, ObservationalView official trial listing → -
Terminated NCT NCT00746252
Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder
Not yet reported University of Maryland, Baltimore 5 participants Est. completion 2010-10 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00749970
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
AstraZeneca 100 participants Est. completion 2009-01 14 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Terminated NCT NCT00750776
KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment
Psychiatric Centre Rigshospitalet 212 participants Est. completion 2012-08 10 sitesOther conditions: Antipsychotic Treatment, Quality Assurance, Medical TreatmentView official trial listing → -
Status unknown NCT NCT00752960
DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics
Genomas, Inc 1000 participants Est. completion 2009-12 2 sitesOther conditions: PsychosesView official trial listing → -
Completed NCT NCT00757705
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia
Not yet reported Johnson & Johnson Taiwan Ltd 299 participants Est. completion 2009-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00761579
Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission
Not yet reported Janssen Korea, Ltd., Korea 190 participants Est. completion 2010-12 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00761605
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
Not yet reported Janssen Korea, Ltd., Korea 387 participants Est. completion 2010-10 8 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00762814
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
Not yet reported Washington University School of Medicine 4 participants Est. completion 2009-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00763438
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
Not yet reported H. Lundbeck A/S 18 participants Est. completion 2010-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00767715
A Study in the Treatment of Acute Mania
Not yet reported Eli Lilly and Company 11 participants Est. completion 2005-04 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT00768326
Efficacy of Lu 31-130 in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 280 participants Est. completion 2009-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00770744
Efficacy of Lu 31-130 in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 93 participants Est. completion 2009-11 21 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT00786318
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
Not yet reported George Washington University Est. completion 2011-07 1 siteOther conditions: Psychosis, Agitation, DeliriumView official trial listing → -
Status unknown NCT NCT00789022
Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment
Shalvata Mental Health Center 80 participants 1 siteOther conditions: Schizophrenia, Schizophreniform, Schizoaffective Disorder, Brief Psychotic EpisodeView official trial listing → -
Status unknown NCT NCT00789906
Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia
BeerYaakov Mental Health Center 700 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00790517
Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)
Not yet reported Kaiser Permanente 200 participants Est. completion 2014-12 3 sitesType 2 diabetes Other conditions: Weight Loss, Psychotic DisordersView official trial listing → -
Completed NCT NCT00790777
A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 72 participants Est. completion 2007-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00791167
A Study of the Dose Proportionality of Extended Release Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 58 participants Est. completion 2006-08Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00791193
A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 2007-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00791232
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113 participants Est. completion 2003-06Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00791284
A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2004-12Other conditions: Schizophrenia, Hepatic ImpairmentView official trial listing → -
Completed NCT NCT00791349
A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141 participants Est. completion 2005-05Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00791401
A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-02Other conditions: Schizophrenia, Renal ImpairmentView official trial listing → -
Completed NCT NCT00791622
A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 110 participants Est. completion 2006-06Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00791713
A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2006-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796029
A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 5 participants Est. completion 2003-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796185
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62 participants Est. completion 2004-01Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00796276
A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2004-08Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796432
A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4 participants Est. completion 2003-06Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796471
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35 participants Est. completion 2003-08Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796640
A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35 participants Est. completion 2003-11Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00796835
A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 50 participants Est. completion 2004-10Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00797927
Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia
Not yet reported National Taiwan University Hospital 30 participants Est. completion 2009-04 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00799383
Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia
Not yet reported Chadi A. Calarge 47 participants Est. completion 2014-03 1 siteOther conditions: Risperidone-induced HyperprolactinemiaView official trial listing → -
Completed NCT NCT00802100
Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
Not yet reported National Institute of Mental Health (NIMH) 21 participants Est. completion 2009-10 13 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00806234
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Not yet reported Johns Hopkins University 127 participants Est. completion 2014-03 4 sitesOther conditions: Psychotic DisordersView official trial listing → -
Completed NCT NCT00809731
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
AstraZeneca 490 participants Est. completion 2010-09 17 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00815854
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects
Not yet reported University of Michigan 88 participants Est. completion 2019-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00816894
D-serine Monotherapy for Schizophrenia
Not yet reported Herzog Hospital 18 participants Est. completion 2013-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00816907
The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)
Not yet reported National Institute of Mental Health (NIMH) 146 participants Est. completion 2010-03 16 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT00817323
What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?
Not yet reported University of British Columbia Est. completion 2013-12Other conditions: Bipolar DepressionView official trial listing → -
Completed NCT NCT00817648
A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia
Not yet reported Shanghai Mental Health Center 120 participants Est. completion 2010-05 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00818298
24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study
Not yet reported Centre for Addiction and Mental Health 12 participants Est. completion 2011-06 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00821600
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 24 participants Est. completion 2009-06 3 sitesOther conditions: Psychotic Disorders, SchizophreniaView official trial listing → -
Status unknown NCT NCT00825045
Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
Not yet reported Centre for Addiction and Mental Health 14 participants Est. completion 2020-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT00827840
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia
Not yet reported Chonnam National University Hospital 58 participants Est. completion 2011-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00828490
Electronic Pharmacotherapy Risk Management
University of Utah 174000 participants Est. completion 2010-03 1 siteOther conditions: Asthma, Mental Health, PainView official trial listing → -
Terminated NCT NCT00833300
Haloperidol vs Olanzapine for the Management of ICU Delirium
Not yet reported Richard Hall 200 participants Est. completion 2011-11 2 sitesOther conditions: Delirium, AgitationView official trial listing → -
Completed NCT NCT00833456
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
AstraZeneca 106 participants Est. completion 2010-11 14 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00833976
Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Not yet reported Massachusetts General Hospital 65 participants Est. completion 2013-03 1 siteOther conditions: High Triglycerides, Hypercholesterolemia, Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT00835107
An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
Not yet reported Queen's University 14 participants Est. completion 2011-06 1 siteOther conditions: Depression, BipolarView official trial listing → -
Completed NCT NCT00836251
Effects of Antipsychotic Medications on Energy Intake and Expenditure
Washington University School of Medicine 15 participants Est. completion 2008-06 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Weight GainView official trial listing → -
Status unknown NCT NCT00837707
Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25 participants Est. completion 2010-02 1 siteOther conditions: Dyskinesia, Drug-InducedView official trial listing → -
Withdrawn NCT NCT00838227
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder
Not yet reported Manhattan Psychiatric Center Est. completion 2012-06Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00838669
A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 74 participants Est. completion 2005-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00842608
Pharmacological Management of Delirium
Not yet reported Indiana University 551 participants Est. completion 2015-07 3 sitesOther conditions: Delirium, Cognitive ImpairmentView official trial listing → -
Completed NCT NCT00845026
A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
Not yet reported Denovo Biopharma LLC 261 participants Est. completion 2010-12 23 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00845572
The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center
Not yet reported The University of Texas Health Science Center at San Antonio 30 participants Est. completion 2010-06 1 siteOther conditions: Schizophrenia, SchizoaffectiveView official trial listing → -
Status unknown NCT NCT00845936
Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics
Not yet reported BeerYaakov Mental Health Center 30 participants Est. completion 2010-05 1 siteOther conditions: Drug Induced Weight GainView official trial listing → -
Completed NCT NCT00845988
Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
Not yet reported Seoul National University Hospital 28 participants Est. completion 2012-03 1 siteOther conditions: Bipolar Disorders, Metabolic ComplicationView official trial listing → -
Completed NCT NCT00854919
Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder
Not yet reported Osaka City University Est. completion 2007-12 1 siteOther conditions: SSRI-Refractory Obsessive-Compulsive DisorderView official trial listing → -
Completed NCT NCT00857064
Subjective Well Being of Schizophrenic Patients in Greece
AstraZeneca 600 participants Est. completion 2009-10 24 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00859664
Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders
Assaf-Harofeh Medical Center 500 participants Est. completion 2011-07 1 siteOther conditions: Autism, Neuroleptic TreatmentView official trial listing → -
Status unknown NCT NCT00861003
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
Korea University Guro Hospital 57 participants Est. completion 2010-08 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00862992
Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia
Not yet reported Tanabe Pharma Corporation 34 participants Est. completion 2009-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00864825
Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia
Not yet reported Sheba Medical Center 248 participants Est. completion 2010-01 33 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00873249
Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
AstraZeneca 339 participants Est. completion 2010-03 25 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT00885690
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)
Not yet reported University of Aarhus 11 participants Est. completion 2012-11 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00888264
A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder
AstraZeneca 152 participants Est. completion 2010-08 45 sitesOther conditions: Bipolar DisordersView official trial listing → -
Completed NCT NCT00888953
Nursing Homes Study of Fall Risk Assessment Oriented to Intervention
Not yet reported Fundacio Salut i Envelliment UAB 331 participants Est. completion 2012-04 1 siteOther conditions: Accidental Falls, Activities of Daily Living, Quality of Life, Self-EfficacyView official trial listing → -
Completed NCT NCT00892125
A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64 participants Est. completion 2007-03Other conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT00892320
A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2004-05Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00892489
A Bioequivalence Study of 15 mg ER OROS Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 2004-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00892541
A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30 participants Est. completion 2004-11Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00894738
Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children
Washington University School of Medicine 44 participants Est. completion 2016-06-01 1 siteOther conditions: Mental DisordersView official trial listing → -
Completed NCT NCT00895921
Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
Not yet reported Veterans Medical Research Foundation 30 participants Est. completion 2010-06 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00903916
Effect of Antipsychotics on Appetite Regulation
University of North Carolina, Chapel Hill 45 participants Est. completion 2012-03 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Withdrawn NCT NCT00910780
Metabolic Effects of Antipsychotic Substitution in Children
Not yet reported, Not yet reported Washington University School of Medicine Est. completion 2009-11Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00910988
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
Not yet reported Washington University School of Medicine 46 participants Est. completion 2012-06 1 siteOther conditions: Hyperglycemia, HyperlipidemiaView official trial listing → -
Completed NCT NCT00922272
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms
Not yet reported Shire 92 participants Est. completion 2011-01-20 27 sitesOther conditions: Schizophrenia and Predominant Negative SymptomsView official trial listing → -
Completed NCT NCT00926965
Tardive Dyskinesia and Cognitive Function
Not yet reported Taipei Veterans General Hospital, Taiwan 80 participants Est. completion 2007-12 1 siteOther conditions: Tardive Dyskinesia, Neurocognitive FunctionView official trial listing → -
Terminated NCT NCT00931996
Oculomotor and Spatial Cognition Deficits in Schizophrenia
Not yet reported University of Illinois Chicago 12 participants Est. completion 2011-11 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00932529
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
Not yet reported University of Bergen 226 participants Est. completion 2010-01 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Terminated NCT NCT00934635
A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls
Not yet reported Janssen-Cilag G.m.b.H 2 participants Est. completion 2009-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00937716
Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies
University of Alabama at Birmingham 75 participants Est. completion 2021-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00937755
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
Taipei Medical University Hospital 80 participants Est. completion 2009-05 1 siteOther conditions: Schizophrenia, AntipsychoticsView official trial listing → -
Completed NCT NCT00946491
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Not yet reported Sandoz 30 participants Est. completion 1987-05Other conditions: PsychosisView official trial listing → -
Completed NCT NCT00952757
Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine
Investigaciones Médicas Montejo S.L. 35 participants Est. completion 2008-08 6 sitesOther conditions: APS-related Hyperprolactinaemia, Schizophrenia, Bipolar DisorderView official trial listing → -
Terminated NCT NCT00954603
A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium
Not yet reported Chiang Mai University 52 participants Est. completion 2012-07 1 siteOther conditions: DeliriumView official trial listing → -
Completed NCT NCT00956189
Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
Not yet reported National Taiwan University Hospital 132 participants Est. completion 2012-10 3 sitesMetabolic syndromeView official trial listing → -
Status unknown NCT NCT00973297
A Targeted Falls Prevention Program in Rehabilitation In-Patients
Not yet reported Hadassah Medical Organization 100 participants Est. completion 2010-11 1 siteOther conditions: Accidental FallsView official trial listing → -
Completed NCT NCT00977301
Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)
Not yet reported Radboud University Medical Center 24 participants Est. completion 2010-08 1 siteOther conditions: HIV InfectionsView official trial listing → -
Terminated NCT NCT00977522
A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia
Not yet reported Pfizer 207 participants Est. completion 2010-09 37 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00981526
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
Not yet reported University of Massachusetts, Worcester 66 participants Est. completion 2012-05 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT00992407
An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder
Not yet reported Janssen Korea, Ltd., Korea 75 participants Est. completion 2010-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT00999505
Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
Not yet reported Hospital de Clinicas de Porto Alegre 40 participants Est. completion 2011-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT00999895
A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients
AstraZeneca 574 participants Est. completion 2010-09 43 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01004354
Vitamin D Supplementation in Psychiatric Illnesses
Not yet reported University of Massachusetts, Worcester 12 participants Est. completion 2010-06 1 siteOther conditions: Obesity, Vitamin D Deficiency, Psychosis, Schizophrenia, Schizoaffective DisorderView official trial listing → -
Status unknown NCT NCT01016145
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
Not yet reported University of Sao Paulo 126 participants Est. completion 2010-07 1 siteOther conditions: Schizophrenia or Schizoaffective DisorderView official trial listing → -
Status unknown NCT NCT01022450
Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients
National Taiwan University Hospital 2500 participants 1 siteOther conditions: Rhabdomyolysis, Myopathy, Acute Renal Failure, Neuroleptic Malignant SyndromeView official trial listing → -
Completed NCT NCT01026285
InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics
Janssen-Cilag International NV 1085 participants Est. completion 2012-03 98 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01029769
Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
Not yet reported Technical University of Munich 350 participants Est. completion 2015-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT01030874
Orthostatic Hypotension Treatment on Rehab Unit
Not yet reported VA Office of Research and Development 356 participants Est. completion 2016-05 1 siteOther conditions: Orthostatic Hypotension, FallsView official trial listing → -
Completed NCT NCT01043250
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
Samsung Medical Center 81 participants Est. completion 2010-12 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01050582
A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244 participants Est. completion 2011-07 28 sites Stand-aloneOther conditions: Schizophrenia, Bipolar Disorder, Autistic Disorder, Conduct and Other Disruptive Behavior DisordersView official trial listing → -
Completed NCT NCT01051531
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
Not yet reported Janssen Research & Development, LLC 546 participants Est. completion 2013-05-17 41 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01052103
A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms
Not yet reported Denovo Biopharma LLC 167 participants Est. completion 2012-06 9 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01052714
Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2
Not yet reported VA Office of Research and Development 121 participants Est. completion 2015-05-28 3 sitesOther conditions: Diabetes, Obesity, Weight GainView official trial listing → -
Status unknown NCT NCT01057849
Standard Comprehensive Intervention to Treat First-episode Schizophrenia
Not yet reported Peking University 600 participants 6 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01066403
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
Not yet reported Heidelberg University 28 participants Est. completion 2008-03 4 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01071135
Quetiapine XR in Schizophrenic Patients
Not yet reported Hannover Medical School 5 participants Est. completion 2010-08 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01075295
Prevention of Weight Gain in Early Psychoses
Not yet reported Centre for Addiction and Mental Health 70 participants Est. completion 2012-12 1 siteOther conditions: Schizophreniform Disorder, Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder, Substance-Induced Psychoses, Psychosis Not Otherwise Specified, Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01081769
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Not yet reported Janssen-Cilag International NV 769 participants Est. completion 2013-02 94 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01082588
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
Not yet reported Massachusetts General Hospital 60 participants Est. completion 2012-09 1 siteOther conditions: Schizophrenia, Schizoaffective Disorders, Schizophreniform DisordersView official trial listing → -
Completed NCT NCT01085383
Aripiprazole and Prolactin Study
Not yet reported University of Oxford 15 participants Est. completion 2014-12 1 siteOther conditions: HyperprolactinemiaView official trial listing → -
Completed NCT NCT01092221
Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode
Not yet reported Sheba Medical Center 180 participants Est. completion 2011-04 24 sitesOther conditions: ManiaView official trial listing → -
Completed NCT NCT01104766
Safety and Efficacy of Cariprazine in Patients With Schizophrenia
Not yet reported Forest Laboratories 617 participants Est. completion 2011-12-20 58 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01104779
Safety and Efficacy of Cariprazine in Schizophrenia
Not yet reported Forest Laboratories 446 participants Est. completion 2011-12-15 41 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01104792
Long-term Study of Cariprazine in Patients With Schizophrenia
Not yet reported Forest Laboratories 752 participants Est. completion 2013-01-31 86 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01116830
A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder
Not yet reported Hoffmann-La Roche 29 participants Est. completion 2014-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01119014
Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis
Not yet reported Anne Katrine Pagsberg 300 participants Est. completion 2015-07 9 sitesOther conditions: PsychosisView official trial listing → -
Completed NCT NCT01125267
Promoting Adherence to Treatment in Schizophrenia
Not yet reported University of California, Los Angeles 174 participants Est. completion 2008-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01129674
A Long-Term, Open-Label, Study on Schizophrenia
Not yet reported, Not yet reported Denovo Biopharma LLC 560 participants Est. completion 2012-10 81 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01139463
Study of Blood Lactate Levels in Patients Treated With Antipsychotics
University of Split 60 participants Est. completion 2009-10 1 siteOther conditions: Movement Disorders, Lactic AcidosisView official trial listing → -
Completed NCT NCT01143077
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Not yet reported Sumitomo Pharma America, Inc. 244 participants Est. completion 2011-05 27 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01145313
Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 501 participants Est. completion 2010-06Other conditions: Depressive Disorder, MajorView official trial listing → -
Completed NCT NCT01152697
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
Not yet reported University Hospitals Cleveland Medical Center 30 participants Est. completion 2012-08 1 siteOther conditions: Patient NoncomplianceView official trial listing → -
Completed NCT NCT01154829
Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
Not yet reported University of Copenhagen 136 participants Est. completion 2016-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01157351
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
Not yet reported Janssen Scientific Affairs, LLC 450 participants Est. completion 2013-12 56 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01160679
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
AstraZeneca 231 participants Est. completion 2011-08 12 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01160991
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
Not yet reported Central Institute of Mental Health, Mannheim 10 participants Est. completion 2006-10 1 siteOther conditions: Schizophrenia, Diabetes, Insulin ResistanceView official trial listing → -
Completed NCT NCT01164059
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
Not yet reported University of Bremen 149 participants Est. completion 2014-03 18 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01174290
Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol
Not yet reported Northeastern University 68 participants Est. completion 2014-03 2 sitesOther conditions: Subsyndromal DeliriumView official trial listing → -
Completed NCT NCT01176721
Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia
Not yet reported cerbomed GmbH 20 participants Est. completion 2012-02 2 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01177709
Metformin for Weight Loss in Schizophrenia
Not yet reported Nathan Kline Institute for Psychiatric Research 12 participants Est. completion 2011-04 1 siteOther conditions: Schizophrenia, ObesityView official trial listing → -
Completed NCT NCT01181960
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Janssen Scientific Affairs, LLC 1066 participants Est. completion 2013-11 34 sitesOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT01184235
Multidimensional Measurement of Psychopharmacological Treatment Response
Child Psychopharmacology Institute 44 participants Est. completion 2011-08 1 siteOther conditions: Autism Spectrum Disorders, Mood Disorders, Sleep Disorders, Attention Deficit DisordersView official trial listing → -
Completed NCT NCT01185418
Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
Chonbuk National University Hospital 80 participants Est. completion 2009-07 1 siteOther conditions: Normal VolunteersView official trial listing → -
Completed NCT NCT01185743
Antipsychotics and Gene Expression in Soft Tissues
Not yet reported Medical University of Vienna 16 participants Est. completion 2017-01-01 1 siteOther conditions: Schizophrenia, DiabetesView official trial listing → -
Completed NCT NCT01189006
Add-On Therapy to Risperidonein Schizophrenia
Not yet reported, Not yet reported National Cheng-Kung University Hospital 161 participants Est. completion 2008-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01192867
A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)
Not yet reported Hoffmann-La Roche 629 participants Est. completion 2014-05-26 122 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01192880
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia
Not yet reported Hoffmann-La Roche 625 participants Est. completion 2014-07 103 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01192906
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)
Not yet reported Hoffmann-La Roche 624 participants Est. completion 2014-07 113 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT01193166
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC Est. completion 2012-09Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01198353
Effectiveness of Ziprasidone for Patients With Schizophrenia
Not yet reported Soonchunhyang University Hospital 67 participants Est. completion 2013-12 6 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01206153
Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients
Not yet reported Central South University 84 participants Est. completion 2010-03 1 siteOther conditions: AmenorrheaView official trial listing → -
Completed NCT NCT01207414
Switching to Iloperidone From Other Antipsychotics in Schizophrenia
Not yet reported Novartis 501 participants Est. completion 2012-01 59 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01211522
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
Not yet reported Vanderbilt University Medical Center 566 participants Est. completion 2018-07-19 16 sitesOther conditions: Delirium, Impaired Cognition, Long Term Psychologic DisordersView official trial listing → -
Completed NCT NCT01212575
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia
AstraZeneca 186 participants Est. completion 2011-02 13 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01214135
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
AstraZeneca 300 participants Est. completion 2010-12 14 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01215383
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
Ziv Hospital 20 participants 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT01222494
Healthy Bodies, Healthy Kids
Not yet reported Washington University School of Medicine 47 participants Est. completion 2017-03 1 siteMetabolic syndrome Other conditions: Child Mental Disorders, ObesityView official trial listing → -
Completed NCT NCT01222793
Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia
National Institute on Drug Abuse (NIDA) 60 participants Est. completion 2012-05-03 1 siteOther conditions: Schizophrenia, ObesityView official trial listing → -
Completed NCT NCT01231074
Reducing Antipsychotic-Induced Weight Gain in Children With Metformin
Not yet reported Nationwide Children's Hospital 96 participants Est. completion 2013-05 1 siteOther conditions: Obesity, Weight Gain, Psychotropic Induced Weight GainView official trial listing → -
Withdrawn NCT NCT01234298
SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia
Not yet reported Shire Est. completion 2014-02-24Other conditions: Negative Symptoms of SchizophreniaView official trial listing → -
Completed NCT NCT01234454
Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI
Not yet reported University of North Carolina, Chapel Hill 34 participants Est. completion 2007-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01235520
A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)
Not yet reported Hoffmann-La Roche 595 participants Est. completion 2014-07 121 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01235559
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)
Not yet reported Hoffmann-La Roche 604 participants Est. completion 2015-03 90 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01235585
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)
Not yet reported Hoffmann-La Roche 597 participants Est. completion 2014-09 120 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01236274
The Risk of Myocardial Infarction in Users of Antipsychotic Agents
London School of Hygiene and Tropical Medicine 90000 participants Est. completion 2014-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01244815
Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)
Not yet reported Organon and Co 404 participants Est. completion 2013-09-17Other conditions: Bipolar Disorder, PediatricView official trial listing → -
Completed NCT NCT01245348
Relative Effectiveness of Schizophrenia Therapy Study
Medco Health Solutions, Inc. 1110 participants Est. completion 2012-12 1 siteOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT01246232
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia
Not yet reported Imperial College London 69 participants Est. completion 2015-03 3 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01259973
Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers
Not yet reported Hospital Clinic of Barcelona 24 participants Est. completion 2011-12 2 sitesOther conditions: Pharmacogenetics, HealthyView official trial listing → -
Completed NCT NCT01269710
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
University of North Carolina, Chapel Hill 4 participants Est. completion 2011-03 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorder, Not Otherwise Specified, Prodromal Schizophrenia, Mood Disorder, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Not Otherwise Specified, Mood Disorder, Not Otherwise Specified, Autism Spectrum DisorderView official trial listing → -
Completed NCT NCT01272531
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
University of California, San Diego 560 participants Est. completion 2016-04 10 sitesOther conditions: Bipolar Affective DisorderView official trial listing → -
Status unknown NCT NCT01280305
Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
Not yet reported Sheba Medical Center 200 participants Est. completion 2013-03 13 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01280396
Metabolic Side-effects for Second-generation Antipsychotics
The University of Hong Kong 241 participants Est. completion 2014-12 1 siteOther conditions: Mental DisordersView official trial listing → -
Completed NCT NCT01281527
Paliperidone Palmitate Flexible Dosing in Schizophrenia
Not yet reported Janssen-Cilag International NV 1044 participants Est. completion 2013-11 127 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01284959
Different Safety Profile of Risperidone and Paliperidone Extended-release
Not yet reported Chonbuk National University Hospital 34 participants Est. completion 2010-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01291368
Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care
University of Aarhus 248 participants Est. completion 2012-02 2 sitesOther conditions: Delirium, Stress Disorders, Post-TraumaticView official trial listing → -
Completed NCT NCT01291511
Relapse Prevention Study in Patients With Schizophrenia
Not yet reported Vanda Pharmaceuticals 635 participants Est. completion 2015-03 63 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01295372
Safety and Efficacy of Zicronapine in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 160 participants 24 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01300364
Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia
Not yet reported Fundació Sant Joan de Déu 249 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01303367
Medication Management and Care of Demented Patients With Behavioral and Psychological Symptoms of Dementia in Taiwan: A Retrospective Pilot Study
Taipei Medical University WanFang Hospital 200 participants Est. completion 2010-12 1 siteOther conditions: DementiaView official trial listing → -
Terminated NCT NCT01305707
Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Not yet reported Hospital Universitari de Bellvitge 104 participants Est. completion 2014-07 3 sitesOther conditions: DepressionView official trial listing → -
Status unknown NCT NCT01320982
Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Sheba Medical Center 400 participants Est. completion 2012-07 14 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01323205
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia
Not yet reported Janssen Research & Development, LLC 100 participants Est. completion 2012-12 20 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01331304
Comparative Effectiveness Study for Bipolar Disorder
Not yet reported Massachusetts General Hospital 482 participants Est. completion 2013-09 11 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT01333072
Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
Not yet reported Medical University of South Carolina 80 participants Est. completion 2015-08 1 siteOther conditions: Autistic DisorderView official trial listing → -
Completed NCT NCT01342120
PHARMO Institute Seroquel Safety Study
AstraZeneca 18325 participants Est. completion 2010-11Other conditions: Schizophrenia, Major Depressive Disorder, Bipolar Disorder, Generalized Anxiety DisorderView official trial listing → -
Completed NCT NCT01347619
iADAPT: Off Label Use of Antipsychotics in the Nursing Home
Not yet reported University of Massachusetts, Worcester 42 participants Est. completion 2013-09 1 siteOther conditions: Off-label Use of Atypical Antipsychotic DrugsView official trial listing → -
Terminated NCT NCT01368458
Conversion to Antipsychotic Monotherapy
Not yet reported Nathan Kline Institute for Psychiatric Research 24 participants Est. completion 2008-07Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01376492
FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain
Janssen-Cilag, S.A. 709 participants Est. completion 2011-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01377233
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
Not yet reported H. Lundbeck A/S 46 participants 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01384279
The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity
Not yet reported Beitou Armed Forces Hospital, Taipei, Taiwan 25 participants Est. completion 2012-01 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01392482
IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
AstraZeneca 751725 participants Est. completion 2012-09 16 sitesOther conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT01394601
A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia
AstraZeneca 600 participants Est. completion 2011-12 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01409590
Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications
Not yet reported Sheba Medical Center 100 participants Est. completion 2009-08 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01411930
Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
Not yet reported Veterans Medical Research Foundation 15 participants Est. completion 2011-08 1 siteOther conditions: DiabetesView official trial listing → -
Terminated NCT NCT01420575
Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia
Not yet reported VA Nebraska Western Iowa Health Care System 8 participants Est. completion 2012-08 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01421342
VA Augmentation and Switching Treatments for Improving Depression Outcomes
Not yet reported VA Office of Research and Development 1522 participants Est. completion 2016-06 35 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT01432444
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 493 participants Est. completion 2013-12 124 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01446328
Bergen Psychosis Project 2 - The Best Intro Study
Not yet reported Haukeland University Hospital 151 participants Est. completion 2017-12 4 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT01447082
General Practice Research Database Seroquel XR Safety Study
AstraZeneca 37372 participants Est. completion 2012-12 1 siteOther conditions: Schizophrenia, Major Depressive Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT01448720
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
Not yet reported Janssen-Cilag Farmaceutica Ltda. 142 participants Est. completion 2013-12 12 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01454453
Optimisation of Antipsychotic Drug Use in Older People
Not yet reported Institute of Psychiatry, London 64 participants Est. completion 2015-07 1 siteOther conditions: Alzheimer's Disease, SchizophreniaView official trial listing → -
Completed NCT NCT01467089
The Assessment of Movement Disorders Utilizing Live Two-Way Video
Northwell Health 37 participants Est. completion 2016-06 1 siteOther conditions: Tardive DyskinesiaView official trial listing → -
Completed NCT NCT01479400
Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study
Central South University 152 participants Est. completion 2011-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01479413
Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs
Chang Gung Memorial Hospital 77 participants Est. completion 2013-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01481883
Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
Not yet reported The Alfred 13 participants Est. completion 2019-02 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT01491412
Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia
AstraZeneca 503 participants Est. completion 2012-05 14 sitesOther conditions: Acute Psychotic Episode, SchizophreniaView official trial listing → -
Withdrawn NCT NCT01495156
Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania
Not yet reported Northwell Health Est. completion 2015-09 1 siteOther conditions: Bipolar I DisorderView official trial listing → -
Completed NCT NCT01495169
Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
Not yet reported Vanda Pharmaceuticals 33 participants Est. completion 2015-02 10 sitesOther conditions: Safety and Tolerability of IloperidoneView official trial listing → -
Completed NCT NCT01499563
Study of a Novel Antipsychotic ITI-007 in Schizophrenia
Not yet reported Intra-Cellular Therapies, Inc. 335 participants Est. completion 2013-11 8 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01509053
Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 30 participants Est. completion 2012-10 10 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01516424
Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone
Not yet reported Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 267 participants Est. completion 2013-02 16 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01527305
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
Not yet reported Janssen Research & Development, LLC 212 participants Est. completion 2013-12-31 21 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01527448
Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II
Not yet reported BC Women's Hospital & Health Centre 26 participants Est. completion 2010-07 1 siteOther conditions: Postpartum DepressionView official trial listing → -
Completed NCT NCT01530308
Haloperidol Prophylaxis in Older Emergency Department Patients
Not yet reported Amsterdam UMC, location VUmc 242 participants Est. completion 2015-10 6 sitesOther conditions: DeliriumView official trial listing → -
Completed NCT NCT01534936
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary
AstraZeneca 2153 participants Est. completion 2012-12 53 sitesOther conditions: Schizophrenia, Affective SymptomsView official trial listing → -
Completed NCT NCT01543321
Xenazine in Late Dyskinetic Syndrome With Neuroleptics
Not yet reported Centre Hospitalier Universitaire, Amiens 54 participants Est. completion 2017-08 19 sitesOther conditions: Tardive DyskinesiaView official trial listing → -
Completed NCT NCT01544608
Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia
AstraZeneca 1076 participants Est. completion 2012-12 7 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01552772
Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 60 participants Est. completion 2012-04 12 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01556763
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia
Not yet reported FORUM Pharmaceuticals Inc 21 participants Est. completion 2008-08 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Central Nervous System DiseasesView official trial listing → -
Withdrawn NCT NCT01567124
Alleviating the Metabolic Side Effects of Antipsychotic Medications
Not yet reported Baker Heart and Diabetes Institute 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01578486
Salsalate as an Adjunctive Treatment for Patients With Schizophrenia
Not yet reported University of Massachusetts, Worcester 17 participants Est. completion 2015-07 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Withdrawn NCT NCT01584466
Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study
Not yet reported University of Maryland, Baltimore Est. completion 2014-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01587118
An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder
Not yet reported Lori Davis, MD 18 participants Est. completion 2016-07 1 siteOther conditions: Posttraumatic Stress DisorderView official trial listing → -
Completed NCT NCT01587521
Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia
Chiang Mai University 80 participants Est. completion 2016-06 1 siteMetabolic syndrome Other conditions: Quality of Life, DepressionView official trial listing → -
Terminated NCT NCT01592201
A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
Not yet reported Janssen Korea, Ltd., Korea 13 participants Est. completion 2013-06 9 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01598623
Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients
Not yet reported Sheba Medical Center 48 participants Est. completion 2014-09 1 siteOther conditions: Oxytocin + Non Specific Counselling, Oxytocin + Social Skills Training, Placebo + Non Specific Counselling, Placebo + Social Skills TrainingView official trial listing → -
Completed NCT NCT01607762
A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics
Not yet reported Janssen Research & Development, LLC 31 participants Est. completion 2012-10 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01609153
Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy
Not yet reported Heinrich-Heine University, Duesseldorf 328 participants Est. completion 2019-04 21 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT01615185
A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia
Not yet reported Kaohsiung Kai-Suan Psychiatric Hospital 96 participants Est. completion 2011-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01621737
Antipsychotic Effects of Oxytocin
Not yet reported University of California, San Diego 42 participants Est. completion 2018-12 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01625000
Safety and Efficacy of MP-214 in Patients With Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 512 participants Est. completion 2015-10 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01625897
A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 125 participants Est. completion 2015-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01626859
A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 38 participants Est. completion 2013-08 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01626872
Long-Term Study of MP-214 in Patients With Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 254 participants Est. completion 2016-10 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01626885
A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia
Not yet reported, Not yet reported Tanabe Pharma Corporation 42 participants Est. completion 2014-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01636037
Antipsychotic Augmentation With L-Dopa
Not yet reported Centre for Addiction and Mental Health 13 participants Est. completion 2016-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01639872
Clozapine for Cannabis Use in Schizophrenia
Not yet reported Dartmouth-Hitchcock Medical Center 49 participants Est. completion 2017-03-29 9 sitesOther conditions: Schizophrenia, Cannabis Abuse, Cannabis Dependence, Dual DiagnosisView official trial listing → -
Completed NCT NCT01646827
An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 37 participants Est. completion 2013-04 6 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01662648
Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia
Not yet reported Janssen Pharmaceutica 1117 participants Est. completion 2009-04Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01670019
Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
Not yet reported Duke University 46 participants Est. completion 2014-06 5 sitesOther conditions: Major Depressive Disorder Without Psychotic FeaturesView official trial listing → -
Status unknown NCT NCT01672554
Clinical Benefits of Seroquel XR in Anxiety Disorder
Not yet reported Corporation de Recherche en Neuropsycho Pharmacologie de Quebec 40 participants Est. completion 2013-10 1 siteOther conditions: Schizophrenia, AnxietyView official trial listing → -
Completed NCT NCT01682161
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
Not yet reported Janssen Korea, Ltd., Korea 154 participants Est. completion 2013-09 9 sitesOther conditions: SchizophreniaView official trial listing → -
Suspended NCT NCT01684657
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Not yet reported University of California, Irvine 32 participants Est. completion 2014-05 1 siteOther conditions: StutteringView official trial listing → -
Completed NCT NCT01685931
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
Not yet reported Xian-Janssen Pharmaceutical Ltd. 617 participants Est. completion 2014-12 17 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01686815
Cross-Sectional Iloperidone IVGTT
Massachusetts General Hospital 37 participants Est. completion 2016-05 1 siteMetabolic syndrome Other conditions: Schizophrenia, Serious Mental Illness, Insulin Resistance, Glucose MetabolismView official trial listing → -
Completed NCT NCT01689389
Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study
AstraZeneca 2292 participants Est. completion 2014-12 19 sitesOther conditions: Schizophrenia, Bipolar EpisodesView official trial listing → -
Status unknown NCT NCT01710163
Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients
Not yet reported University of Sao Paulo 50 participants Est. completion 2015-06 2 sitesOther conditions: Bipolar I DisorderView official trial listing → -
Completed NCT NCT01714661
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Not yet reported FORUM Pharmaceuticals Inc 753 participants Est. completion 2015-12 94 sitesOther conditions: Schizophrenia, Impaired CognitionView official trial listing → -
Completed NCT NCT01714713
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Not yet reported FORUM Pharmaceuticals Inc 830 participants Est. completion 2015-10 128 sitesOther conditions: Schizophrenia, Impaired CognitionView official trial listing → -
Completed NCT NCT01716975
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Not yet reported FORUM Pharmaceuticals Inc 767 participants Est. completion 2016-02 106 sitesOther conditions: Schizophrenia, Impaired CognitionView official trial listing → -
Completed NCT NCT01720095
Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis
Not yet reported Nova Scotia Health Authority 22 participants Est. completion 2014-12 1 siteOther conditions: PsychosisView official trial listing → -
Completed NCT NCT01724359
Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia
Not yet reported Janssen-Cilag, S.A. 95 participants Est. completion 2009-11 5 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT01724372
The Role of Antidepressants or Antipsychotics in Preventing Psychosis
Not yet reported St. Luke's-Roosevelt Hospital Center Est. completion 2014-05Other conditions: Psychotic DisorderView official trial listing → -
Completed NCT NCT01726335
Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia
Not yet reported Janssen-Cilag Ltd. 53 participants Est. completion 2008-03 5 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01731119
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
Not yet reported University of North Carolina, Chapel Hill 9 participants Est. completion 2014-08 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS, Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive, Bipolar I Disorder, Bipolar II Disorder, Mood Disorder NOS, Severe Major Depression With Psychotic Features, Single Episode Major Depression Without Psychotic Symptoms, Severe Mood Disorder With Psychotic FeaturesView official trial listing → -
Terminated NCT NCT01738698
Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia
Not yet reported Shire 4 participants Est. completion 2013-04-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01739127
Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
University of British Columbia 83 participants Est. completion 2016-02 1 siteMetabolic syndrome Other conditions: Psychotic Disorders, Bipolar DisorderView official trial listing → -
Status unknown NCT NCT01752465
Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders?
Not yet reported University of British Columbia 40 participants Est. completion 2016-09 1 siteMetabolic syndrome Other conditions: Psychotic DisordersView official trial listing → -
Withdrawn NCT NCT01758887
Antipsychotic Discontinuation in High-risk Subjects
Seoul National University Hospital Est. completion 2016-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01760889
SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia
Not yet reported Shire 1 participants Est. completion 2013-04-01 4 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT01760993
Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia
Not yet reported Shire 2 participants Est. completion 2013-04-01 2 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01765829
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
Not yet reported Fundación Pública Andaluza Progreso y Salud 104 participants Est. completion 2015-11 17 sitesOther conditions: Psychosis Nos/OtherView official trial listing → -
Completed NCT NCT01778244
Metformin for Treatment of Antipsychotic-induced Dyslipidemia
Not yet reported Central South University 162 participants Est. completion 2012-06 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01779700
Fingolimod in Schizophrenia Patients
Not yet reported Indiana University 40 participants Est. completion 2016-08 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01786239
Omega-3 Dietary Supplements in Schizophrenia
Not yet reported Delbert Robinson 50 participants Est. completion 2015-09 1 siteOther conditions: Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Bipolar Disorder, Psychosis NOSView official trial listing → -
Completed NCT NCT01786369
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
Northwell Health 106 participants Est. completion 2015-04 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT01794429
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue
Not yet reported Bjorn H. Ebdrup 45 participants Est. completion 2015-06 1 siteMetabolic syndrome Other conditions: Obesity, Drug-induced Obesity, SchizophreniaView official trial listing → -
Completed NCT NCT01797575
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
Not yet reported The University of Texas Health Science Center, Houston 38 participants Est. completion 2017-02-01 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT01804582
The Family VOICE Study
Not yet reported University of Maryland, Baltimore 350 participants Est. completion 2016-03-31 1 siteOther conditions: Autism, Aggression, Bipolar Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT01811160
Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics
Not yet reported Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50 participants Est. completion 2011-11 1 siteOther conditions: Second Generation Antipsychotic Induced Metabolic Adverse EffectsView official trial listing → -
Completed NCT NCT01811459
Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium
Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 107 participants Est. completion 2016-09 1 siteOther conditions: DeliriumView official trial listing → -
Completed NCT NCT01822418
Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
Not yet reported Central Institute of Mental Health, Mannheim 27 participants Est. completion 2015-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Delusional DisorderView official trial listing → -
Completed NCT NCT01825798
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
Not yet reported Holland Bloorview Kids Rehabilitation Hospital 60 participants Est. completion 2015-10 4 sitesOther conditions: Overweight, Autism Spectrum DisorderView official trial listing → -
Status unknown NCT NCT01831986
Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders
Not yet reported Sha'ar Menashe Mental Health Center 60 participants Est. completion 2013-12Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT01844700
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
Not yet reported Northwell Health 14 participants Est. completion 2014-04 1 siteOther conditions: High Risk MC4R Genotype, Low Risk MC4R Genotype, One Week or Less Antipsychotic Lifetime ExposureView official trial listing → -
Status unknown NCT NCT01845259
Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
Not yet reported Psychiatric Centre Rigshospitalet 103 participants Est. completion 2017-03 1 sitePrediabetesView official trial listing → -
Completed NCT NCT01851863
Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia
Not yet reported RenJi Hospital 262 participants Est. completion 2014-06 1 siteOther conditions: Dyspepsia, Compliance, DepressionView official trial listing → -
Completed NCT NCT01852331
Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia
Not yet reported The University of Hong Kong 103 participants Est. completion 2014-11 4 sitesOther conditions: Schizophrenia, Schizophrenic Disorder, Hyperprolactinemia, HyperprolactinaemiaView official trial listing → -
Completed NCT NCT01855074
An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders
Not yet reported Janssen-Cilag Ltd. 80 participants Est. completion 2009-02Other conditions: Schizophrenia, Schizophreniform Disorder, Schizoaffective DisorderView official trial listing → -
Status unknown NCT NCT01855152
Improving Well-being and Health for People With Dementia
Not yet reported professor Clive Ballard 1000 participants Est. completion 2015-03 1 siteOther conditions: DementiaView official trial listing → -
Completed NCT NCT01858948
SGA-induced Metabolic Syndrome in Bipolar Youth
Not yet reported University of Cincinnati 19 participants Est. completion 2018-04 1 siteOther conditions: Bipolar Youth Treated With Second-generation AntipsychoticsView official trial listing → -
Completed NCT NCT01866098
Naltrexone for Antipsychotic-Induced Weight Gain
Not yet reported Yale University 144 participants Est. completion 2019-04-07 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar Disorder, Severe Major Depression With Psychotic FeaturesView official trial listing → -
Terminated NCT NCT01867398
Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders
National Institute of Mental Health (NIMH) 12 participants Est. completion 2015-05-18 1 siteOther conditions: Conduct Disorder, fMRIView official trial listing → -
Completed NCT NCT01871974
Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
Not yet reported Astellas Pharma Inc 16 participants Est. completion 2010-03 2 sitesOther conditions: Major Depressive Disorder PatientsView official trial listing → -
Completed NCT NCT01871987
Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2009-08 1 siteOther conditions: Healthy, Plasma Concentration Change of QuetiapineView official trial listing → -
Completed NCT NCT01875822
Open-label Study of Curcumin C-3 Complex in Schizophrenia
Not yet reported, Not yet reported Woodbury, Michel, M.D. 17 participants Est. completion 2012-05 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, DepressionView official trial listing → -
Completed NCT NCT01875861
Monitoring and Management for Metabolic Side Effects of Antipsychotics
Not yet reported VA Office of Research and Development 12 participants Est. completion 2017-04 1 siteOther conditions: Mental Health, Psychotic DisordersView official trial listing → -
Status unknown NCT NCT01885923
A RCT Study in Schizophrenia Relapse Prevention
Not yet reported Prague Psychiatric Center 150 participants Est. completion 2015-12 1 siteOther conditions: Relapse SchizophreniaView official trial listing → -
Completed NCT NCT01888107
Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder
Not yet reported Janssen-Cilag S.p.A. 347 participants Est. completion 2007-04Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Terminated NCT NCT01894984
An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 640 participants Est. completion 2009-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01903200
Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder
Not yet reported Astellas Pharma Inc 16 participants Est. completion 2011-09 2 sitesOther conditions: Major Depressive Disorder PatientsView official trial listing → -
Terminated NCT NCT01908192
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Not yet reported, Not yet reported SyneuRx International (Taiwan) Corp 60 participants Est. completion 2023-10-26 23 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01908296
Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2011-08 1 siteOther conditions: Healthy, Pharmacokinetics of QuetiapineView official trial listing → -
Terminated NCT NCT01913327
Antipsychotic Effects on Brain Function in Schizophrenia
Not yet reported University of California, San Francisco 4 participants Est. completion 2017-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT01920802
Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo
Not yet reported New York State Psychiatric Institute 31 participants Est. completion 2014-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01924520
Oral Multiple-dose Study in Patients With Major Depressive Disorder
Not yet reported Astellas Pharma Inc 32 participants Est. completion 2011-05 2 sitesOther conditions: Major Depressive DisorderView official trial listing → -
Terminated NCT NCT01929889
Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia
Not yet reported Northwestern University 19 participants Est. completion 2014-10 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT01931059
Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers
Not yet reported Northwell Health 11 participants Est. completion 2016-07 1 siteOther conditions: Imaging of the Brain and Antipsychotics, Neuronal Network ChangesView official trial listing → -
Status unknown NCT NCT01936220
Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 200 participants Est. completion 2016-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01938859
Algorithm Guided Treatment Strategies for Bipolar Depression
Not yet reported Shanghai Mental Health Center 360 participants Est. completion 2018-12 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT01947803
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
Not yet reported Xian-Janssen Pharmaceutical Ltd. 353 participants Est. completion 2015-03 12 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01953237
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
Not yet reported University of Maryland, Baltimore 31 participants Est. completion 2015-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT01962402
Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study
Not yet reported Southern California Institute for Research and Education 15 participants 1 siteOther conditions: Weight GainView official trial listing → -
Status unknown NCT NCT01966588
Adverse Events and Genomics in Schizophrenia
University of British Columbia 100 participants Est. completion 2017-03 1 siteOther conditions: Adverse Effect of Other Antipsychotics and NeurolepticsView official trial listing → -
Completed NCT NCT01976793
Retrospective Observational Study DIANA Study
AstraZeneca 450 participants Est. completion 2013-12 8 sitesOther conditions: Major Depressive EpisodeView official trial listing → -
Completed NCT NCT01977300
Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode
Not yet reported University of British Columbia 159 participants Est. completion 2011-08 1 siteOther conditions: Bipolar I DisorderView official trial listing → -
Completed NCT NCT01990755
Neurobiology of Eating Disorders Treatments
Not yet reported University of Turin, Italy 112 participants Est. completion 2013-05 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT01994109
Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects
Not yet reported Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187 participants Est. completion 2017-01 34 sitesOther conditions: SialorrheaView official trial listing → -
Completed NCT NCT01999309
Simvastatin Addition for Patients With Recent-onset Schizophrenia
Not yet reported Iris Sommer 121 participants Est. completion 2019-12-19 2 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOSView official trial listing → -
Completed NCT NCT02007928
Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic
Not yet reported Centre Hospitalier Universitaire de Nice 200 participants Est. completion 2017-07 14 sitesOther conditions: Dissociative Disorders, SchizophreniaView official trial listing → -
Completed NCT NCT02009371
A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder
Not yet reported Peking University 80 participants Est. completion 2015-07 1 siteOther conditions: Depressive Episodes of Bipolar DisorderView official trial listing → -
Completed NCT NCT02013531
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 37 participants Est. completion 2014-06 21 sitesOther conditions: Major Depressive Disorder, AnxietyView official trial listing → -
Completed NCT NCT02013609
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2014-10 24 sitesOther conditions: MDDView official trial listing → -
Completed NCT NCT02013622
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 49 participants Est. completion 2014-10 22 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02019329
A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone
Not yet reported Hoffmann-La Roche 32 participants Est. completion 2014-08 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT02020356
Music Therapy in Alzheimer's Disease
Not yet reported University Hospital, Toulouse 35 participants Est. completion 2015-06 7 sitesOther conditions: Alzheimer's Type DementiaView official trial listing → -
Completed NCT NCT02029989
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Not yet reported University of Minnesota 121 participants Est. completion 2012-02 1 siteOther conditions: Hyperlipidemia, Diabetes, HypertensionView official trial listing → -
Completed NCT NCT02034253
Glutamate, Brain Connectivity and Duration of Untreated Psychosis
University of Alabama at Birmingham 134 participants Est. completion 2018-11 1 siteOther conditions: Schizophrenia, Psychosis, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02037074
Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics
Not yet reported FORUM Pharmaceuticals Inc 40 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02040883
Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia
Not yet reported Qingyun Yin 100 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02051387
Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
Not yet reported Central Institute of Mental Health, Mannheim 74 participants Est. completion 2017-08 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02054702
Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 97 participants Est. completion 2014-07Other conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02070211
Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Not yet reported, Not yet reported Bambino Gesù Hospital and Research Institute 80 participants Est. completion 2016-06 1 siteOther conditions: 22q11 Deletion SyndromeView official trial listing → -
Completed NCT NCT02079844
Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia
Not yet reported Takeda 20 participants Est. completion 2015-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02085447
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness
Not yet reported University Hospitals Cleveland Medical Center 30 participants Est. completion 2016-12 1 siteOther conditions: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Medication Adherence, Medication Non-AdherenceView official trial listing → -
Completed NCT NCT02087579
Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2014-12 24 sitesOther conditions: Psychotic Disorders, Schizophrenia, Bipolar Disorder, Depressive DisorderView official trial listing → -
Status unknown NCT NCT02093858
The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome
Central South University 212 participants Est. completion 2017-12 1 siteMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02109939
Genomics Used to Improve DEpression Decisions
Not yet reported Assurex Health Inc. 1398 participants Est. completion 2017-07-31 61 sitesOther conditions: Major Depressive Disorder (MDD)View official trial listing → -
Completed NCT NCT02137278
Stop Vasodepressor Drugs in Reflex Syncope
Not yet reported Gruppo Italiano Multidisciplinare per lo Studio della Sincope 58 participants Est. completion 2015-12 1 siteOther conditions: Hypotensive SyncopeView official trial listing → -
Status unknown NCT NCT02137616
Antipsychotic to Treat Psychosis Syndrome
Not yet reported Central South University 300 participants Est. completion 2014-12 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Completed NCT NCT02142556
The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics
Not yet reported Tri-Service General Hospital (TSGH) 61 participants Est. completion 2012-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02146547
European Long-acting Antipsychotics in Schizophrenia Trial
Not yet reported UMC Utrecht 536 participants Est. completion 2020-08-26 49 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02151656
F17464 in Acute Schizophrenia Trial
Not yet reported Pierre Fabre Medicament 158 participants Est. completion 2015-12 27 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02181803
Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003)
Not yet reported Merck Sharp & Dohme LLC 55 participants Est. completion 2015-04-23Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02184767
Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 30 participants Est. completion 2015-05 2 sitesOther conditions: BiPolarView official trial listing → -
Completed NCT NCT02192723
A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
Not yet reported Beijing HuiLongGuan Hospital 550 participants Est. completion 2014-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02194933
Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 38 participants Est. completion 2016-04 1 siteOther conditions: Schizophrenia With ImpulsivityView official trial listing → -
Status unknown NCT NCT02205437
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia
Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT02212613
Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. Est. completion 2015-11 1 siteOther conditions: Major Depressive Disorder and IrritabilityView official trial listing → -
Withdrawn NCT NCT02213887
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
Not yet reported University of British Columbia Est. completion 2020-11-02 1 siteOther conditions: Psychotic Disorders, Gastroesophageal RefluxView official trial listing → -
Completed NCT NCT02220504
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Not yet reported Fundación Marques de Valdecilla 68 participants Est. completion 2014-07 1 siteOther conditions: Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Completed NCT NCT02237417
Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism
Not yet reported University of Utah 47 participants Est. completion 2020-07-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02239094
Biosignatures of Latuda for Bipolar Depression
Not yet reported New York State Psychiatric Institute 20 participants Est. completion 2016-09 1 siteOther conditions: Bipolar DepressionView official trial listing → -
Status unknown NCT NCT02240173
Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia
Not yet reported, Not yet reported Federal Neuro-Psychiatric Hospital, Yaba 100 participants Est. completion 2017-12 1 siteOther conditions: Schizophrenia and Disorders With Psychotic FeaturesView official trial listing → -
Completed NCT NCT02248987
Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia
Seoul National University Hospital 36 participants Est. completion 2016-05 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02281162
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain
Creighton University 20 participants Est. completion 2015-09 1 siteMetabolic syndrome Other conditions: Schizophrenia, Vitamin D DeficiencyView official trial listing → -
Completed NCT NCT02281773
A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.
Not yet reported Boehringer Ingelheim 518 participants Est. completion 2016-06-13 43 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02282085
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
Not yet reported Matt Byerly 200 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02282761
A Trial to Assess the Antipsychotic Efficacy of ITI-007
Not yet reported Intra-Cellular Therapies, Inc. 450 participants Est. completion 2015-09 11 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT02286206
Study of the Effect of Dosing on Clozapine Levels
Not yet reported University of British Columbia Est. completion 2017-12 1 siteOther conditions: Psychotic Disorders, SchizophreniaView official trial listing → -
Completed NCT NCT02295462
Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial
Not yet reported Martin-Luther-Universität Halle-Wittenberg 1158 participants Est. completion 2017-02 3 sitesOther conditions: DementiaView official trial listing → -
Completed NCT NCT02298985
Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Not yet reported Beersheva Mental Health Center 38 participants Est. completion 2017-05 2 sitesOther conditions: Chronic SchizophreniaView official trial listing → -
Completed NCT NCT02305823
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
Not yet reported Fundación Marques de Valdecilla 203 participants Est. completion 2014-05 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT02307396
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Not yet reported Technical University of Munich 21 participants Est. completion 2016-06-22 1 siteOther conditions: Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective DisordersView official trial listing → -
Status unknown NCT NCT02334904
Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
University of British Columbia 60 participants Est. completion 2016-06 1 siteOther conditions: First-Episode Psychosis, Bipolar DisorderView official trial listing → -
Completed NCT NCT02339844
Pan European Collaboration on Antipsychotic Naïve Schizophrenia II
Not yet reported University of Copenhagen 130 participants Est. completion 2021-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT02357849
Fluoxetine vs Aripiprazole Comparative Trial (FACT)
Not yet reported Northwell Health 9 participants Est. completion 2022-04-04 1 siteOther conditions: Attenuated Psychosis SyndromeView official trial listing → -
Completed NCT NCT02360319
Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
Not yet reported Vanguard Research Group 489 participants Est. completion 2019-03-31 39 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02361255
Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism
Corporal Michael J. Crescenz VA Medical Center 40 participants Est. completion 2019-04 1 siteOther conditions: Secondary Parkinsonism, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
Not yet reported University Health Network, Toronto 60 participants Est. completion 2017-04 2 sitesOther conditions: Bipolar DepressionView official trial listing → -
Withdrawn NCT NCT02363816
Beta-carotene and Oxidative Stress in Pediatric Second Generation Antipsychotic Use
Wayne State UniversityOther conditions: Pediatric Population on Second Generation AntipsychoticsView official trial listing → -
Completed NCT NCT02366897
Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics
Not yet reported University of Edinburgh 21 participants Est. completion 2018-06-30 1 siteOther conditions: Drug-induced Extrapyramidal Side EffectsView official trial listing → -
Completed NCT NCT02374996
Pharmacoepigenetics of Bipolar Disorder Treatment
Wayne State University 40 participants Est. completion 2017-09 1 siteOther conditions: Antipsychotic Agents, Bipolar DisorderView official trial listing → -
Completed NCT NCT02409823
Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
Pontifical Catholic University of Argentina 665 participants Est. completion 2015-08Other conditions: Schizophrenia, Major Depressive Disorder, Bipolar Depressive Disorder, Parkinson's Disease With HallucinationsView official trial listing → -
Status unknown NCT NCT02423096
Neuroendocrine and Metabolite Substrates in Schizophrenia
Chang Gung Memorial Hospital 200 participants Est. completion 2016-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02423824
Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
Not yet reported University Health Network, Toronto 21 participants Est. completion 2016-05 1 siteOther conditions: Bipolar Disorder, Major Depressive DisorderView official trial listing → -
Completed NCT NCT02431702
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
Not yet reported Janssen Scientific Affairs, LLC 337 participants Est. completion 2019-11-12 38 sitesOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Terminated NCT NCT02435095
Antipsychotic Induced Structural and Functional Brain Changes
Not yet reported RWTH Aachen University 174 participants Est. completion 2020-08 11 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02435654
5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia
Not yet reported Kunming Medical University 128 participants Est. completion 2018-12 1 siteOther conditions: Early-onset SchizophreniaView official trial listing → -
Completed NCT NCT02440594
The PACE/PACENET Behavioral Health Laboratory Project
Not yet reported University of Pennsylvania 2432 participants Est. completion 2015-06 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT02442817
Linagliptin and Mesenchymal Stem Cells: A Pilot Study
Not yet reported University of Nevada, Reno 10 participants Est. completion 2018-03-02 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02447835
Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction
Not yet reported Michael Rickels 15 participants Est. completion 2014-12 1 siteOther conditions: Normal Non-fluencyView official trial listing → -
Terminated NCT NCT02462473
A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
Not yet reported Janssen Research & Development, LLC 9 participants Est. completion 2016-01 3 sitesOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02466477
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Not yet reported Assurex Health Inc. 542 participants Est. completion 2019-09 14 sitesOther conditions: Depressive Disorder, Major, Depression, Depressive DisorderView official trial listing → -
Completed NCT NCT02469155
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
Not yet reported Intra-Cellular Therapies, Inc. 696 participants Est. completion 2016-08 11 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02496650
Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU
Not yet reported Bogomolets National Medical University 70 participants Est. completion 2015-06Other conditions: Alcohol Withdrawal StateView official trial listing → -
Completed NCT NCT02500628
Heart Rate Variability in Response to Metformin Challenge
Not yet reported Woodinville Psychiatric Associates 61 participants Est. completion 2016-02 1 siteType 2 diabetes Other conditions: Fibromyalgia, Mitochondrial Diseases, Movement DisordersView official trial listing → -
Terminated NCT NCT02503124
Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression
Not yet reported Sahlgrenska University Hospital 32 participants Est. completion 2020-03-15 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT02504450
Outcomes of Antipsychotic Medication Used in the Emergency Department
Wake Forest University Health Sciences 93 participants Est. completion 2016-03Other conditions: Agitation,PsychomotorView official trial listing → -
Completed NCT NCT02504476
Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective
Not yet reported Amgen 52 participants Est. completion 2016-02 2 sitesOther conditions: Schizophrenia or Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02515773
Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
Not yet reported Melissa Delbello 1565 participants Est. completion 2023-06 29 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT02526030
Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
Not yet reported Fundación Marques de Valdecilla 203 participants Est. completion 2015-06 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Status unknown NCT NCT02532491
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
Not yet reported Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT02534363
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
Not yet reported Fundación Marques de Valdecilla 136 participants Est. completion 2013-01 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT02536846
The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals
Not yet reported Dost Ongur 35 participants Est. completion 2019-11-08 1 siteOther conditions: HealthyView official trial listing → -
Withdrawn NCT NCT02546336
Ultrasound-Guided Hip Joint Cooled Radiofrequency Denervation
Not yet reported Women's College Hospital Est. completion 2019-02-01 1 siteOsteoarthritis Other conditions: Chronic PainView official trial listing → -
Status unknown NCT NCT02562287
Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder
Not yet reported Hospital de Clinicas de Porto Alegre 54 participants Est. completion 2020-12 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT02573168
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics
Not yet reported St. Joseph's Healthcare Hamilton 103 participants Est. completion 2020-09 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02573701
Guideline vs Usual Treatment in Schizophrenic Adolescents
Not yet reported Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico 91 participants Est. completion 2015-07Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02582736
Antipsychotics and Risk of Hyperglycemic Emergencies
Canadian Network for Observational Drug Effect Studies, CNODES 725489 participants Est. completion 2012-12 1 siteType 2 diabetes Other conditions: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT02593058
Positive Emotions Program for Schizophrenia (PEPS)
Not yet reported Institut et Haute Ecole de la Santé la Source 80 participants Est. completion 2018-12-31 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02593734
Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
Not yet reported University of Ghana Medical School 139 participants Est. completion 2015-07 1 siteOther conditions: Schizophrenia, Mood Disorders,, Anxiety DisorderView official trial listing → -
Completed NCT NCT02600741
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
Janssen Scientific Affairs, LLC 296 participants Est. completion 2018-07-05 34 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02604056
Pragmatic Cluster Trial for Nursing Home Antipsychotic Prescribing
Not yet reported Women's College Hospital 60 participants Est. completion 2017-04Other conditions: Adverse Effect of Other Antipsychotics and NeurolepticsView official trial listing → -
Completed NCT NCT02610868
Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults
Not yet reported Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187 participants Est. completion 2017-06 35 sitesOther conditions: SialorrheaView official trial listing → -
Completed NCT NCT02634346
A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
Not yet reported Alkermes, Inc. 403 participants Est. completion 2017-06-07 31 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02634463
Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
Not yet reported Janssen Research & Development, LLC 81 participants Est. completion 2016-11-09 1 siteOther conditions: Immunoassay, AntipsychoticView official trial listing → -
Completed NCT NCT02640300
Switching Antipsychotics: Abrupt Discontinuation Versus Overlap
Not yet reported Centre for Addiction and Mental Health 33 participants Est. completion 2004-07 1 site Stand-aloneOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02644577
Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
Not yet reported China Medical University, China 110 participants Est. completion 2015-09 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Status unknown NCT NCT02650102
The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
Not yet reported, Not yet reported Shanxi Medical University 200 participants Est. completion 2016-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02653339
Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.
Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2018-08 1 siteOther conditions: Rhinitis, Allergic, PerennialView official trial listing → -
Completed NCT NCT02654964
Cancer Stem Cell High-Throughput Drug Screening Study
Not yet reported Swedish Medical Center 9 participants Est. completion 2023-06 1 siteOther conditions: Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT02697045
Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
Not yet reported Abdi İbrahim Otsuka 23 participants Est. completion 2018-03-31 15 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02704962
Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine
Not yet reported Kaohsiung Kai-Suan Psychiatric Hospital 94 participants Est. completion 2016-02 2 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02708394
Molecular Mechanisms of Antipsychotic-induced Insulin Resistance
Not yet reported Wayne State University 31 participants Est. completion 2023-10-01 1 siteOther conditions: Adverse Effect of Other Antipsychotics and Neuroleptics, Insulin ResistanceView official trial listing → -
Completed NCT NCT02712463
A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics
Janssen-Cilag Ltd. 310 participants Est. completion 2016-04 11 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02713672
Cost-effectiveness of CYP2D6 and CYP2C19 Genotyping in Psychiatric Patients in Curacao
Not yet reported GGZ Centraal 86 participants Est. completion 2015-06 1 siteOther conditions: CYP2D6, Psychiatric PatientsView official trial listing → -
Terminated NCT NCT02717130
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
Not yet reported Florida Atlantic University 9 participants Est. completion 2017-05-25 4 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02731612
Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients
Not yet reported Lakshmi N Yatham 100 participants Est. completion 2024-12-31 9 sitesOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT02744313
MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use
Centre for Addiction and Mental Health 17 participants Est. completion 2018-04 1 siteOther conditions: AdiposityView official trial listing → -
Completed NCT NCT02775864
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
New York State Psychiatric Institute 81921 participants Est. completion 2018-06Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02787122
Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia
Not yet reported Philipps University Marburg 64 participants Est. completion 2017-12-31 2 sitesOther conditions: Schizophrenia, Delusional Disorder, Schizoaffective Disorder, Brief Psychotic Disorder, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT02787135
Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis
Not yet reported Philipps University Marburg 94 participants Est. completion 2019-12-31 2 sitesOther conditions: Schizophrenia, Psychotic Disorders, Delusions, Emotions, Self-esteem, SleepView official trial listing → -
Completed NCT NCT02818777
A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease
Not yet reported University of Colorado, Denver 13 participants Est. completion 2017-11 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT02820519
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
Not yet reported University of Witten/Herdecke 4 participants Est. completion 2017-05-04 1 siteOther conditions: Neuropathic PainView official trial listing → -
Completed NCT NCT02824055
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
Not yet reported Hoffmann-La Roche 33 participants Est. completion 2017-04-24 3 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02827331
Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up
University Hospital, Toulouse 171861 participants Est. completion 2016-04Other conditions: Drug ExpositionView official trial listing → -
Status unknown NCT NCT02850445
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
Not yet reported Guangzhou Psychiatric Hospital 170 participants 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02874560
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia
Janssen-Cilag Ltd. 364 participants Est. completion 2017-07-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02877823
Improving Cardiometabolic Health of Youth on Antipsychotic Medication
Not yet reported University of Maryland, Baltimore 302 participants Est. completion 2021-12-31Other conditions: Childhood ObesityView official trial listing → -
Status unknown NCT NCT02880995
[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis
Not yet reported Seoul National University Hospital 62 participants Est. completion 2019-12 2 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT02884518
Predicting Antipsychotic Discontinuation in Psychosis
Not yet reported Seoul National University Hospital 35 participants Est. completion 2019-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02897167
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients
Fundación Marques de Valdecilla 150 participants Est. completion 2019-03 1 siteOther conditions: Schizophrenia, Mental Disorders, Psychotic DisordersView official trial listing → -
Status unknown NCT NCT02906501
Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
Shalvata Mental Health Center 45 participants Est. completion 2018-03 1 siteOther conditions: ADHDView official trial listing → -
Status unknown NCT NCT02907437
Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia
Not yet reported Beer Yaakov - Ness Ziona Mental Health Center 40 participants Est. completion 2018-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02909491
Ionized Calcium and Behavioural Disorders in Older Adults (CALICO Study)
University Hospital, Angers 90 participants Est. completion 2017-04-27 1 siteOther conditions: Geriatric DisordersView official trial listing → -
Completed NCT NCT02918370
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
Not yet reported University of Texas Southwestern Medical Center 75 participants Est. completion 2023-06-30 1 siteOther conditions: Bipolar Disorder, Alcoholism, Alcohol AbuseView official trial listing → -
Active, not recruiting NCT NCT02926859
Enhancing Recovery in Early Schizophrenia
Not yet reported Central Institute of Mental Health, Mannheim 180 participants Est. completion 2027-12 6 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02928965
The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms
Not yet reported University of Manchester 207 participants Est. completion 2016-05Other conditions: Schizophrenia and Disorders With Psychotic FeaturesView official trial listing → -
Status unknown NCT NCT02935998
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
Not yet reported Yang Fude 1000 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02949752
Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
Not yet reported Institute of Mental Health, Singapore 67 participants Est. completion 2020-01-01 1 siteOther conditions: Antipsychotics Weight GainView official trial listing → -
Completed NCT NCT02953639
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics
Not yet reported Hoffmann-La Roche 214 participants Est. completion 2019-12-12 37 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02958800
Deprescribing Antipsychotics in Long-Term Care
Not yet reported McMaster University 6 participants Est. completion 2019-08 1 siteOther conditions: Dementia, BehaviorView official trial listing → -
Status unknown NCT NCT02964923
Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia
Xijing Hospital 300 participants Est. completion 2017-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02970292
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
Not yet reported ACADIA Pharmaceuticals Inc. 396 participants Est. completion 2019-06-25 105 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02970305
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)
Not yet reported ACADIA Pharmaceuticals Inc. 403 participants Est. completion 2019-10-28 101 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT02970721
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
Western University, Canada 3357 participants Est. completion 2018-05Other conditions: Bipolar Disorder, Pregnancy ComplicationsView official trial listing → -
Completed NCT NCT02983188
Berberine as Adjuvant Treatment for Schizophrenia Patients
Not yet reported, Not yet reported The University of Hong Kong 113 participants Est. completion 2021-01-04 1 siteMetabolic syndrome Other conditions: Schizophrenia, Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Status unknown NCT NCT02986490
Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs
Not yet reported University Hospital, Montpellier 100 participants Est. completion 2017-12 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Bipolar DisorderView official trial listing → -
Completed NCT NCT03005769
Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy
Otsuka Pharmaceutical Europe Ltd 262 participants Est. completion 2017-07 20 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03007303
The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients
Dalian Seventh People's Hospital 30 participants Est. completion 2020-07 1 siteOther conditions: Schizophrenia, MicrognathiaView official trial listing → -
Completed NCT NCT03019887
Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
Not yet reported Juntendo University 139 participants Est. completion 2017-01Other conditions: Schizophrenia RelapseView official trial listing → -
Status unknown NCT NCT03062033
Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Neurocrine Biosciences 70 participants Est. completion 2018-08 34 sitesOther conditions: Tardive DyskinesiaView official trial listing → -
Status unknown NCT NCT03080194
The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia
Not yet reported Maosheng Fang 150 participants Est. completion 2018-04Other conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03090490
10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
Not yet reported Fundación Marques de Valdecilla 68 participants Est. completion 2020-12 1 siteOther conditions: Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Status unknown NCT NCT03090503
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
Not yet reported Fundación Marques de Valdecilla 200 participants Est. completion 2021-06 1 siteOther conditions: Schizophrenia, Psychotic Disorders, PsychosisView official trial listing → -
Completed NCT NCT03093467
Effectiveness of an Internet-based Intervention for the Treatment of Depression
Not yet reported Instituto Milenio para Investigación en Depresión y Personalidad 167 participants Est. completion 2019-11-13 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT03101319
Role of Vitamin D Supplementation in Schizophrenia
Not yet reported Central Institute of Psychiatry, Ranchi, India 73 participants Est. completion 2021-06-22 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03110471
Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation
Swansea University 60 participants Est. completion 2018-03-30 10 sitesOther conditions: DementiaView official trial listing → -
Completed NCT NCT03116100
Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey
Centre Hospitalier Universitaire, Amiens 30 participants Est. completion 2017-10-15 1 siteOther conditions: Behavior Disorders, NeurolepticView official trial listing → -
Terminated NCT NCT03121586
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
Not yet reported ACADIA Pharmaceuticals Inc. 995 participants Est. completion 2024-05-30 161 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03125252
Impact of Non-pharmacological Prevention Measures on the Incidence of Delirium in Adult Intensive Care Units
Not yet reported University Hospital, Toulouse 379 participants Est. completion 2020-11 14 sitesOther conditions: DeliriumView official trial listing → -
Status unknown NCT NCT03130465
Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia
Otsuka Pharmaceutical Europe Ltd 636 participants Est. completion 2020-01-31 67 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03130478
Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain
Otsuka Pharmaceutical Europe Ltd 119 participants Est. completion 2018-07-30 15 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03147521
Accidental Falls Care Bundle
Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 10000 participants Est. completion 2017-01-31Other conditions: Accidental FallsView official trial listing → -
Completed NCT NCT03148639
Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia
Not yet reported Ciusss de L'Est de l'Île de Montréal 19 participants Est. completion 2017-12-02 1 siteAlcohol use disorder Other conditions: Treatment-resistant SchizophreniaView official trial listing → -
Terminated NCT NCT03152292
The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study
ACADIA Pharmaceuticals Inc. 764 participants Est. completion 2021-03-08 69 sitesOther conditions: Parkinson Disease PsychosisView official trial listing → -
Status unknown NCT NCT03155685
Use of Antipsychotics in Palliative Care (NEUROPAL)
University Hospital, Caen 100 participants Est. completion 2018-05Other conditions: Antipsychotics in Palliative CareView official trial listing → -
Status unknown NCT NCT03192631
Financial Incentives to Improve Acceptance of Antipsychotic Injections
Not yet reported Focus Community Mental Health Team 20 participants Est. completion 2021-12-31Other conditions: Schizophrenia, Schizo Affective Disorder, Bipolar I DisorderView official trial listing → -
Status unknown NCT NCT03237052
Validating and Optimizing Model of Antipsychotics Selection
Not yet reported Shanghai Mental Health Center 2000 participants Est. completion 2020-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03248180
Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States
National Taiwan University Hospital 160 participants Est. completion 2020-12-31 1 siteOther conditions: Psychosis, RemissionView official trial listing → -
Status unknown NCT NCT03284294
Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia
Not yet reported Universitas Padjadjaran 40 participants Est. completion 2020-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03319953
A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia
Not yet reported Neurocrine Biosciences 23 participants Est. completion 2019-11-06 1 siteOther conditions: Stable SchizophreniaView official trial listing → -
Terminated NCT NCT03351244
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
Not yet reported Boehringer Ingelheim 264 participants Est. completion 2021-03-31 59 sitesOther conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT03360474
Implementation of a Delirium Screening
Not yet reported University of Miami Est. completion 2018-12Other conditions: Delirium, Cancer, Bone Marrow AblationView official trial listing → -
Status unknown NCT NCT03369795
Add-on Methotrexate for the Treatment of Schizophrenia
Not yet reported Sheba Medical Center 100 participants Est. completion 2020-01-01Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03376763
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 201 participants Est. completion 2021-11-19 27 sitesOther conditions: Schizophrenia, Antipsychotics, Long-Acting Injection, LAI, AripiprazoleView official trial listing → -
Completed NCT NCT03388554
The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia
Not yet reported Tri-Service General Hospital (TSGH) 60 participants Est. completion 2018-03-02 1 siteAlcohol use disorder Other conditions: Schizophrenia, Schizoaffective Disorder, Neurocognitive Dysfunction, Autonomic Imbalance, Psychosocial Impairment, Quality of LifeView official trial listing → -
Completed NCT NCT03389425
Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study
Not yet reported University of Calgary 9 participants Est. completion 2015-10-08Other conditions: Obesity, Abdominal ObesityView official trial listing → -
Status unknown NCT NCT03390712
Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection
Réseau de Santé Vitalité Health Network 328 participants Est. completion 2018-12 4 sitesOther conditions: Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Completed NCT NCT03408873
CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
Not yet reported Martha Sajatovic 30 participants Est. completion 2020-05-06 1 siteOther conditions: Bipolar Disorder, Medication Adherence, Medication Non AdherenceView official trial listing → -
Active, not recruiting NCT NCT03414151
Gut Microbiome in AP Naive
Centre for Addiction and Mental Health 25 participants Est. completion 2026-08 1 siteOther conditions: Psychotic Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT03418675
Brexpiprazole in Borderline Personality Disorder
Not yet reported University of Chicago 80 participants Est. completion 2021-04-14 1 siteOther conditions: Borderline Personality DisorderView official trial listing → -
Completed NCT NCT03427892
Brexpiprazole for Bipolar Depression
Not yet reported University of Texas Southwestern Medical Center 21 participants Est. completion 2018-03-15 1 siteOther conditions: Bipolar DepressionView official trial listing → -
Completed NCT NCT03430596
a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics
Not yet reported Shanghai Mental Health Center 50 participants Est. completion 2021-12-30 1 siteOther conditions: Extrapyramidal SyndromeView official trial listing → -
Status unknown NCT NCT03434210
The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia
Not yet reported Yi Li MD, PhD 110 participants Est. completion 2020-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT03442101
Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study
University of Alabama at Birmingham 156 participants Est. completion 2026-12-31 1 siteOther conditions: PsychosisView official trial listing → -
Completed NCT NCT03448575
Safer Use of Antipsychotics in Youth
Not yet reported Kaiser Permanente 733 participants Est. completion 2021-12-24 4 sitesOther conditions: Child Behavior DisordersView official trial listing → -
Completed NCT NCT03451734
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
Central South University 2000 participants Est. completion 2021-06-30 1 siteMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT03471013
Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia
University Hospital, Clermont-Ferrand 50 participants Est. completion 2026-02-02 1 siteOther conditions: DSM-5 SchizophreniaView official trial listing → -
Status unknown NCT NCT03481192
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
Not yet reported University Hospital, Toulouse 103 participants Est. completion 2019-01 1 siteOther conditions: Suicide, Drug PoisoningView official trial listing → -
Status unknown NCT NCT03481465
Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis
Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 siteMetabolic syndrome Other conditions: Schizophrenia, PsychosisView official trial listing → -
Completed NCT NCT03510325
Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)
Not yet reported Shanghai Mental Health Center 762 participants Est. completion 2023-09-27 7 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03522168
Long-term Antipsychotic Pediatric Safety Trial
Duke University 509 participants Est. completion 2023-11-21 37 sitesOther conditions: Weight, BodyView official trial listing → -
Completed NCT NCT03526354
Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder
Not yet reported University of Massachusetts, Worcester 50 participants Est. completion 2024-02-29 4 sitesSubstance use disorder Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT03535636
Sleep Impairments in Refugees Diagnosed With PTSD
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 40 participants Est. completion 2023-02-07 1 siteOther conditions: PTSD, Sleep DisorderView official trial listing → -
Completed NCT NCT03537040
Piloting MOL Intervention for Neuroleptic Decision Making
Not yet reported University of Manchester 5 participants Est. completion 2019-05-10 2 sitesOther conditions: Psychosis, Medication AdherenceView official trial listing → -
Terminated NCT NCT03537547
Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
Not yet reported Washington University School of Medicine 6 participants Est. completion 2019-08-19 1 siteOther conditions: Major Depressive Disorder, Depression, Depressive Disorder, Depressive Episode, Depression, UnipolarView official trial listing → -
Completed NCT NCT03548155
Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia
Not yet reported Tianjin Anding Hospital 65 participants Est. completion 2017-05-08Other conditions: Schizophrenia, TherapeuticsView official trial listing → -
Completed NCT NCT03557593
Optimizing Prescribing of Antipsychotics in Long-Term Care
Not yet reported Queen's University Est. completion 2017-12Other conditions: DementiaView official trial listing → -
Completed NCT NCT03557931
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Not yet reported Astellas Pharma Global Development, Inc. 233 participants Est. completion 2019-10-21 27 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03559426
Research Into Antipsychotic Discontinuation and Reduction Trial
Not yet reported University College, London 253 participants Est. completion 2022-03-10 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Delusional Disorder, Schizophreniform DisordersView official trial listing → -
Completed NCT NCT03565068
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)
Not yet reported Merck Sharp & Dohme LLC 75 participants Est. completion 2020-04-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03568500
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 44 participants Est. completion 2019-09-06 5 sitesOther conditions: Schizophrenia, Schizoaffective Disorder, First Episode PsychosisView official trial listing → -
Terminated NCT NCT03628391
Haloperidol for Delirium in Adult Critically Ill Patients
Not yet reported Erasmus Medical Center 142 participants Est. completion 2021-01-23 8 sitesOther conditions: Delirium, Critical Illness, Intensive Care Psychosis, Cognitive Impairment, Cognitive DeclineView official trial listing → -
Completed NCT NCT03629951
A Study for Schizophrenia Relapse Prediction
Janssen Research & Development, LLC 333 participants Est. completion 2021-12-31 10 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03639558
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Not yet reported Joseph Dib 100 participants Est. completion 2019-07-07 2 sitesOther conditions: Psychiatric Emergency, Aggression, AgitationView official trial listing → -
Terminated NCT NCT03643159
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 2 participants Est. completion 2018-10-17 5 sitesOther conditions: Schizophrenia, Bipolar 1 Disorder, Major Depressive DisorderView official trial listing → -
Status unknown NCT NCT03651674
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
Not yet reported Xidian University 200 participants Est. completion 2020-04-01Other conditions: Schizophrenia, Bipolar DisorderView official trial listing → -
Completed NCT NCT03663465
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
Not yet reported Calo Psychiatric Center 135 participants Est. completion 2014-07-31Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03666715
A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal
Janssen-Cilag Farmaceutica Ltda. 55 participants Est. completion 2021-05-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT03675750
Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism
Shanghai Mental Health Center 120 participants Est. completion 2020-10-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03692182
The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)
Tabula Rasa HealthCare 10000 participants Est. completion 2019-03 1 siteOther conditions: Behavioral and Psychiatric Symptoms of DementiaView official trial listing → -
Status unknown NCT NCT03693794
A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 270 participants Est. completion 2020-12-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03695289
Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Serious Mental Illness
Not yet reported Washington University School of Medicine 30 participants Est. completion 2020-06-25 1 siteOther conditions: Obesity, Mentally Ill PersonsView official trial listing → -
Completed NCT NCT03701100
The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia
Not yet reported Tri-Service General Hospital (TSGH) 60 participants Est. completion 2018-09-21 1 siteOther conditions: Schizophrenia, Insight Impaired, Psychotic Symptoms, Schizoaffective Disorder, Neurocognitive Dysfunction, Autonomic Imbalance, Psychosocial Impairment, Quality of LifeView official trial listing → -
Status unknown NCT NCT03708549
Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients
Not yet reported Tianjin Anding Hospital 100 participants Est. completion 2023-12-01 1 siteMetabolic syndrome Other conditions: Schizophrenia, Berberine, MetforminView official trial listing → -
Status unknown NCT NCT03708614
A Study Looking at How Well Children With Autism Spectrum Disorder on Medications Like Having More Protein
Not yet reported Holland Bloorview Kids Rehabilitation Hospital 10 participants Est. completion 2020-06 1 siteOther conditions: Autism Spectrum DisorderView official trial listing → -
Suspended NCT NCT03718156
The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial
Not yet reported McGill University 800 participants Est. completion 2026-06 6 sitesOther conditions: Delirium, DementiaView official trial listing → -
Completed NCT NCT03730857
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
Not yet reported Calo Psychiatric Center 111 participants Est. completion 2008-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03741478
Intranasal Insulin and Olanzapine Study in Healthy Volunteers
Not yet reported Centre for Addiction and Mental Health 46 participants Est. completion 2026-06-01 2 sitesOther conditions: Healthy ControlsView official trial listing → -
Completed NCT NCT03749629
Comparative Effectiveness of Pharmacogenomics for Treatment of Depression
Not yet reported Massachusetts General Hospital 201 participants Est. completion 2022-03-15 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT03772951
The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia
Not yet reported Shanghai Mental Health Center 154 participants Est. completion 2021-03-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03788759
Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia
Not yet reported, Not yet reported Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 48 participants Est. completion 2021-12-01 1 siteOther conditions: Schizophrenia, Oxidative StressView official trial listing → -
Status unknown NCT NCT03790345
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
Not yet reported, Not yet reported Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 45 participants Est. completion 2021-11-03 1 siteOther conditions: Schizophrenia, Drug Induced Movement Disorder, Unspecified, Oxidative StressView official trial listing → -
Completed NCT NCT03818256
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications
Not yet reported Corcept Therapeutics 71 participants Est. completion 2022-07-06 27 sitesOther conditions: Antipsychotic-induced Weight Gain (AIWG)View official trial listing → -
Completed NCT NCT03822910
Hippocampal Memory Circuits in Delusions
NYU Langone Health 212 participants Est. completion 2023-08-12 3 sitesOther conditions: PsychosisView official trial listing → -
Completed NCT NCT03848234
Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder
Not yet reported Tangent Data 209 participants Est. completion 2016-07-29 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisordersView official trial listing → -
Terminated NCT NCT03852706
EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED)
Not yet reported University of Dublin, Trinity College 4 participants Est. completion 2022-03-25 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03863691
Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.
Not yet reported Philipps University Marburg 85 participants Est. completion 2020-07-15 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT03865719
Weight Management Intervention for Youth and Young Adults With Autism Spectrum Disorder
Not yet reported University of Pittsburgh 10 participants Est. completion 2021-12-01 1 siteOther conditions: Autism Spectrum DisorderView official trial listing → -
Status unknown NCT NCT03883204
Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Not yet reported Fundación Marques de Valdecilla 115 participants Est. completion 2020-12 1 siteOther conditions: Schizophrenia, Psychotic Disorders, PsychosisView official trial listing → -
Completed NCT NCT03887754
Therapeutic Issues for Autism
Not yet reported Minia University 80 participants Est. completion 2018-12Other conditions: Autism Spectrum DisorderView official trial listing → -
Terminated NCT NCT03892889
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 277 participants Est. completion 2020-09-29 68 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT03955549
Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial
Not yet reported Agiad Psychiatry Hospital 99 participants Est. completion 2021-01-30 1 siteOther conditions: Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Status unknown NCT NCT03962426
Efficacy of Social Cognitive Training (SCT) in Recent-onset Psychosis
Not yet reported Ludwig-Maximilians - University of Munich 66 participants Est. completion 2020-02-29 1 siteOther conditions: PsychosisView official trial listing → -
Status unknown NCT NCT03972735
Assessment of the Effectiveness of the NECT Program
Not yet reported Hospital Center Alpes-Isère 120 participants Est. completion 2023-04-01 11 sitesOther conditions: Schizophrenia, Bipolar Disorder, Borderline Personality Disorder, Social Function, Self-stigmaView official trial listing → -
Withdrawn NCT NCT03994965
The Sub-Sero Study
Not yet reported Bjorn H. Ebdrup Est. completion 2024-12-04Other conditions: Schizophrenia, PsychosisView official trial listing → -
Completed NCT NCT04002258
Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment
Shanghai Mental Health Center 10363 participants Est. completion 2022-10-25 1 siteOther conditions: Schizophrenia, Antipyretics Toxicity, Prolactin ExcessView official trial listing → -
Completed NCT NCT04002700
A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group
Janssen Research & Development, LLC 1234412 participants Est. completion 2019-05-31 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04010864
A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)
Shanghai Mental Health Center 600 participants Est. completion 2022-12 1 siteOther conditions: Clinical High-riskView official trial listing → -
Completed NCT NCT04038788
Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia
Not yet reported Tri-Service General Hospital (TSGH) 36 participants Est. completion 2019-05-17 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Symptoms, Neurocognitive Dysfunction, Insight Impaired, Quality of Life, Psychosocial Impairment, Autonomic Imbalance, EEG With Abnormally Slow FrequenciesView official trial listing → -
Completed NCT NCT04038957
A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 22 participants Est. completion 2023-06-06 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT04064476
The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk
Huazhong University of Science and Technology 225 participants Est. completion 2021-09-15 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04076371
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
Not yet reported Beijing HuiLongGuan Hospital 1640 participants Est. completion 2018-12Other conditions: SchizophreniaView official trial listing → -
Withdrawn NCT NCT04087109
MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2022-01-31 1 siteOther conditions: Polypharmacy, Deprescribing, Adverse Drug EventView official trial listing → -
Status unknown NCT NCT04093518
Estradiol as add-on to Antipsychotics
Not yet reported Tangent Data 100 participants Est. completion 2020-11-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform DisordersView official trial listing → -
Status unknown NCT NCT04181346
Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting
Not yet reported Faculdade de Medicina do ABC 82 participants Est. completion 2020-02-28 1 siteOther conditions: NauseaView official trial listing → -
Terminated NCT NCT04203056
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Not yet reported University of California, Los Angeles 15 participants Est. completion 2022-10-01 1 siteOther conditions: Schizophrenia, Schizoaffective Disorder, Depressive Type, Schizophreniform DisorderView official trial listing → -
Completed NCT NCT04218981
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
Not yet reported Central South University 200 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Common Mental DisorderView official trial listing → -
Status unknown NCT NCT04224441
Repurposing Chlorpromazine in the Treatment of Glioblastoma
Not yet reported Marco G Paggi, MD, PhD 41 participants Est. completion 2022-12-15 3 sitesOther conditions: Glioblastoma Multiforme, MGMT-Unmethylated GlioblastomaView official trial listing → -
Completed NCT NCT04271046
STAR Caregivers - Virtual Training and Follow-up
Not yet reported Kaiser Permanente 67 participants Est. completion 2023-09-21 1 siteOther conditions: Alzheimer Disease, Dementia, Caregiver BurnoutView official trial listing → -
Completed NCT NCT04280965
Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury
Not yet reported The University of Texas Health Science Center at San Antonio 28 participants Est. completion 2022-10-17 1 siteOther conditions: Post Traumatic Stress DisorderView official trial listing → -
Withdrawn NCT NCT04288193
Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study
Tabula Rasa HealthCare Est. completion 2022-05-18 1 siteOther conditions: Behavioral and Psychiatric Symptoms of Dementia, InsomniaView official trial listing → -
Status unknown NCT NCT04291469
Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 200 participants Est. completion 2022-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04312503
Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"
Aziende Chimiche Riunite Angelini Francesco S.p.A 95 participants Est. completion 2022-10-31 18 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04317807
R33: Levetiracetam in Early Psychosis
Not yet reported NYU Langone Health 65 participants Est. completion 2025-04-10 1 siteOther conditions: Early PsychosisView official trial listing → -
Completed NCT NCT04327843
Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)
Not yet reported Case Western Reserve University 22 participants Est. completion 2020-07-30 1 siteOther conditions: Schizophrenia, Medication Nonadherence, Schizo Affective DisorderView official trial listing → -
Status unknown NCT NCT04332601
Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia
Not yet reported University Hospital, Montpellier 200 participants Est. completion 2025-11Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04373590
Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis
Not yet reported Temple University 18 participants Est. completion 2020-08-30 1 siteOther conditions: Early PsychosisView official trial listing → -
Status unknown NCT NCT04395326
Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population
St. Justine's Hospital 120 participants Est. completion 2025-12-31 1 siteOther conditions: Adverse Drug EventView official trial listing → -
Status unknown NCT NCT04409626
Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference Study
Zealand University Hospital 31740 participants Est. completion 2020-08Other conditions: Hyponatremia, SIADHView official trial listing → -
Terminated NCT NCT04421456
Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment
Not yet reported Jazz Pharmaceuticals 95 participants Est. completion 2022-03-16 39 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT04446234
Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
Not yet reported Shanghai Mental Health Center 350 participants Est. completion 2022-12-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04461119
Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
Not yet reported Newron Pharmaceuticals SPA 138 participants Est. completion 2021-03-13 14 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04524403
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
Not yet reported Corcept Therapeutics 150 participants Est. completion 2022-08-25 40 sitesOther conditions: Antipsychotic-induced Weight Gain (AIWG)View official trial listing → -
Status unknown NCT NCT04528095
SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia
Not yet reported Shanghai Mental Health Center 162 participants Est. completion 2022-12 1 siteOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Status unknown NCT NCT04529226
Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis
Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 75 participants Est. completion 2025-12-30 20 sitesOther conditions: Psychosis, Intellectual DisabilityView official trial listing → -
Completed NCT NCT04531982
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
Not yet reported ACADIA Pharmaceuticals Inc. 454 participants Est. completion 2024-02-19 102 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT04546178
Psychotherapy for Psychosis, Adverse Events, and Substance Misuse
Not yet reported Nova Scotia Health Authority 19 participants Est. completion 2023-09-30 1 siteOther conditions: Psychotic Disorders, Stress Disorders, Traumatic, Substance UseView official trial listing → -
Status unknown NCT NCT04562324
Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
Not yet reported Tianjin Anding Hospital 60 participants Est. completion 2023-11 1 siteOther conditions: Anxiety Disorder, HealthyView official trial listing → -
Status unknown NCT NCT04575103
Monitoring of Arrhythmias in Patients Treated With Antipsychotics
Not yet reported Herlev and Gentofte Hospital 600 participants Est. completion 2024-12-31 18 sitesSubstance use disorder Other conditions: Arrythmia, Antipsychotics and Neuroleptics ToxicityView official trial listing → -
Status unknown NCT NCT04602585
The Effect of Psycho-education on Clinical Outcomes Among Patients With a First Episode Psychosis in Central Uganda
Not yet reported Makerere University 80 participants Est. completion 2023-10-30Other conditions: PsychosisView official trial listing → -
Status unknown NCT NCT04700930
CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia
Not yet reported Psychiatric Hospital of the University of Basel 31 participants Est. completion 2021-10-31 1 siteOther conditions: Schizophrenia and Other Psychotic Disorders, Harm ReductionView official trial listing → -
Completed NCT NCT04745026
Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
Not yet reported Jazz Pharmaceuticals 103 participants Est. completion 2023-12-21 23 sitesOther conditions: Autism Spectrum DisorderView official trial listing → -
Withdrawn NCT NCT04761861
Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia
Not yet reported Sadat City University Est. completion 2025-12-31 1 siteOther conditions: Schizophrenia, DyslipidemiasView official trial listing → -
Terminated NCT NCT04771299
Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients
Not yet reported Lakshmi N Yatham 1 participants Est. completion 2024-09-08 1 siteOther conditions: Bipolar I Disorder, Cognitive ImpairmentView official trial listing → -
Status unknown NCT NCT04807634
Role of Intravenous Lipid Emulsion in Improving Coma of Acute Antipsychotics Poisoning
Not yet reported Ain Shams University 30 participants Est. completion 2021-09 1 siteOther conditions: ComaView official trial listing → -
Completed NCT NCT04851691
An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions
Not yet reported University of California, Los Angeles 158 participants Est. completion 2023-08-14 1 siteOther conditions: Alzheimer Disease, Dementia Alzheimers, Dementia of Alzheimer TypeView official trial listing → -
Completed NCT NCT04856124
Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
Psych Atlanta 10 participants Est. completion 2021-03-01 1 siteOther conditions: Treatment Resistant DepressionView official trial listing → -
Completed NCT NCT04860830
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia
Not yet reported Boehringer Ingelheim 609 participants Est. completion 2024-11-20 110 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT04892199
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
Not yet reported Anders Fink-Jensen, MD, DMSci 104 participants Est. completion 2026-08-01 3 sitesType 2 diabetes Other conditions: Metabolic Disturbance, Schizophrenia, Clozapine, GLP-1, OlanzapineView official trial listing → -
Status unknown NCT NCT04895488
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
Not yet reported, Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 37 participants Est. completion 2025-12-20 1 siteOther conditions: Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic DisorderView official trial listing → -
Completed NCT NCT04898270
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
Not yet reported Taichung Veterans General Hospital 30 participants Est. completion 2021-04-20 1 siteMetabolic syndrome Other conditions: Schizophrenia; Psychosis, Flupentixol, Antipsychotic Agents, Central Nervous System Diseases, Clinical Therapy, Olanzapine, QuetiapineView official trial listing → -
Completed NCT NCT04940039
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings
Not yet reported Janssen-Cilag International NV 93 participants Est. completion 2024-04-16 5 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT04975035
A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine
Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2012-07-01Other conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT05022524
Exploring Novel Uses of Microbiota Therapy for Managing the Side Effects of Psychiatric Pharmaceutical Interventions
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2024-08-31 1 siteOther conditions: Depression, AnxietyView official trial listing → -
Completed NCT NCT05033119
PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
Ulla Schierup Nielsen 90 participants Est. completion 2024-12-31 3 sitesMetabolic syndrome Other conditions: Hyperprolactinemia, Puberty Disorders, Growth Disorders, Antipsychotics and Neuroleptics ToxicityView official trial listing → -
Completed NCT NCT05039489
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
Not yet reported Central South University 200 participants Est. completion 2023-11-30 1 site Stand-aloneOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05110157
Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia
Not yet reported Neurocrine Biosciences 442 participants Est. completion 2025-02-18 87 sitesOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT05146245
Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT
Not yet reported Erasmus Medical Center 140 participants Est. completion 2024-05 1 siteOther conditions: Autism Spectrum DisorderView official trial listing → -
Completed NCT NCT05165316
European Long-acting Antipsychotics in Schizophrenia Trial-II
Rene Kahn 159 participants Est. completion 2026-02-13 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05169268
Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia
The University of Hong Kong 6 participants Est. completion 2026-01-31 1 siteOther conditions: Schizophrenia and Related Disorders, Anxiety DepressionView official trial listing → -
Completed NCT NCT05172687
The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia
Columbia University 336460 participants Est. completion 2018-12-31 3 sitesOther conditions: Alzheimer Disease, Dementia, Prescribing, Off-LabelView official trial listing → -
Completed NCT NCT05243251
Olanzapine Anorexia Cachexia
Not yet reported Cairo University 164 participants Est. completion 2022-12-14 1 siteOther conditions: AnorexiaView official trial listing → -
Terminated NCT NCT05259631
Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS
Not yet reported Negovsky Reanimatology Research Institute 2 participants Est. completion 2023-01-20 1 siteOther conditions: Acute Respiratory Distress SyndromeView official trial listing → -
Completed NCT NCT05281640
Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial
Not yet reported Edinburgh Napier University 57 participants Est. completion 2023-08-31 2 sitesOther conditions: Psychosis, Complex Post-Traumatic Stress Disorder, SchizophreniaView official trial listing → -
Completed NCT NCT05326347
A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia
Not yet reported Otsuka Pharmaceutical Co., Ltd. 247 participants Est. completion 2025-09-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT05333003
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
Not yet reported Centre for Addiction and Mental Health 92 participants Est. completion 2026-08 1 siteOther conditions: Schizophrenia Spectrum DisordersView official trial listing → -
Completed NCT NCT05356013
Caplyta in Borderline Personality Disorder
Not yet reported University of Chicago 60 participants Est. completion 2025-12-31 1 siteOther conditions: Borderline Personality DisorderView official trial listing → -
Completed NCT NCT05390736
Evaluating the Cost Effectiveness of STEADI
Not yet reported National Opinion Research Center 780 participants Est. completion 2023-09-18 1 siteOther conditions: Accidental FallView official trial listing → -
Completed NCT NCT05402111
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 31 participants Est. completion 2023-09-27 7 sitesOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT05416658
Shared Decision Making for Antipsychotic Medications
Not yet reported New York State Psychiatric Institute 120 participants Est. completion 2027-06-30Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Delusional Disorder, Other Specified Schizophrenia Spectrum and Other Psychotic DisorderView official trial listing → -
Completed NCT NCT05422131
Clozapine Therapy Sample Collection - Method Comparison Study
Saladax Biomedical, Inc. 153 participants Est. completion 2023-05-16 1 siteOther conditions: Patients Prescribed ClozapineView official trial listing → -
Withdrawn NCT NCT05433402
Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer
Not yet reported, Not yet reported Sadat City University Est. completion 2022-09-30 1 siteOther conditions: Colon Cancer Stage IIIView official trial listing → -
Completed NCT NCT05461885
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial
Not yet reported Copenhagen University Hospital, Rigshospitalet 226 participants Est. completion 2026-01-04 4 sitesOther conditions: Affective Disorder, PsychosisView official trial listing → -
Completed NCT NCT05463770
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 15 participants Est. completion 2023-08-22 8 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05473741
Risk of Breakthrough Symptoms With Long-Acting Injectable Medications
Centre for Addiction and Mental Health 51 participants Est. completion 2025-10-27 1 siteOther conditions: Schizophrenia, Schizophrenia RelapseView official trial listing → -
Status unknown NCT NCT05498441
Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode
Not yet reported Jiangsu Province Nanjing Brain Hospital 120 participants Est. completion 2024-12-31 1 siteOther conditions: Major Depressive EpisodeView official trial listing → -
Terminated NCT NCT05528224
Effect of SC-ICBT for Adults With OCD:A Three-Arm Randomized Controlled Trial
Not yet reported Shanghai Mental Health Center 46 participants Est. completion 2024-03-31 1 siteOther conditions: Obsessive-Compulsive DisorderView official trial listing → -
Status unknown NCT NCT05537558
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
University Hospital Muenster 300 participants Est. completion 2024-01-09 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT05542264
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 19 participants Est. completion 2024-02-12 4 sitesOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT05545891
Aripiprazole in Body Focused Repetitive Behaviors
Not yet reported University of Chicago 100 participants Est. completion 2027-12 1 siteOther conditions: Trichotillomania (Hair-Pulling Disorder), DermatillomaniaView official trial listing → -
Withdrawn NCT NCT05554627
VA Aripiprazole vs Esketamine for Treatment Resistant Depression
Not yet reported VA Office of Research and Development Est. completion 2023-10-27 26 sitesOther conditions: Depressive Disorder, MajorView official trial listing → -
Terminated NCT NCT05603104
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Not yet reported Dr. Inge Winter 1 participants Est. completion 2026-06-24 1 siteOther conditions: Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar DepressionView official trial listing → -
Completed NCT NCT05628103
A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 101 participants Est. completion 2024-04-01 25 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05633108
A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders
Eisai Co., Ltd. 579728 participants Est. completion 2023-09-30 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Status unknown NCT NCT05646264
A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
Not yet reported Shanghai Mental Health Center 220 participants Est. completion 2023-08-01 1 site Stand-aloneOther conditions: Schizophrenia, Negative Symptoms in SchizophreniaView official trial listing → -
Status unknown NCT NCT05647980
Transmural Collaborative Care Model for CVRM and Medication Review for Patients Using Antipsychotics
Not yet reported Radboud University Medical Center 480 participants Est. completion 2024-11-01 1 siteOther conditions: Mental Disorders, SevereView official trial listing → -
Completed NCT NCT05650788
Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects
Not yet reported University Hospital, Clermont-Ferrand 60 participants Est. completion 2024-07-17 1 siteOther conditions: Bipolar Disorder Type II, Mood Depressive DisorderView official trial listing → -
Terminated NCT NCT05654870
Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia
Not yet reported Neurocrine Biosciences 8 participants Est. completion 2023-11-08 3 sitesOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT05662306
C-Cog in Early Course Schizophrenia Study
Not yet reported University of Miami 1 participants Est. completion 2025-03-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05663749
Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 60 participants Est. completion 2023-08-20 1 siteMetabolic syndrome Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05667961
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation
Shanghai Mental Health Center 480 participants Est. completion 2025-03-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05686772
Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis
Laval University 520 participants Est. completion 2023-05-01 2 sitesOther conditions: Gambling Disorder, Psychotic DisordersView official trial listing → -
Completed NCT NCT05690698
Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium
Not yet reported Alexandria University 100 participants Est. completion 2023-07-15 1 siteOther conditions: Hyperactive DeliriumView official trial listing → -
Completed NCT NCT05716802
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia
Not yet reported Hebei Province Veterans Hospital 60 participants Est. completion 2022-07-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Terminated NCT NCT05741502
An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine
Not yet reported Ohio State University 5 participants Est. completion 2026-01-23 1 siteOther conditions: Treatment-resistant SchizophreniaView official trial listing → -
Completed NCT NCT05741528
An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 75 participants Est. completion 2024-09-23 16 sitesOther conditions: SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT05748990
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
Not yet reported Centre for Addiction and Mental Health 20 participants Est. completion 2026-12-31 1 siteOther conditions: Schizophrenia, HealthyView official trial listing → -
Status unknown NCT NCT05762146
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
Not yet reported Maastricht University 28 participants Est. completion 2024-04-30 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT05766007
Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum
University of Liverpool 168 participants Est. completion 2025-11-21 6 sitesOther conditions: Schizophrenia, Psychosis, Mania, Pregnancy, Drug Exposure in Utero, Drug Exposure Via Breast Milk, Antipsychotic Agents, BreastfeedingView official trial listing → -
Completed NCT NCT05830708
The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males
Not yet reported Universiti Sains Malaysia 58 participants Est. completion 2024-06-30 1 site Stand-aloneAlcohol use disorderView official trial listing → -
Completed NCT NCT05838625
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia
Not yet reported Click Therapeutics, Inc. 464 participants Est. completion 2025-07-23 54 sitesOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT05850585
A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 100 participants Est. completion 2026-12Other conditions: SchizophreniaView official trial listing → -
Completed NCT NCT05857566
Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine
Not yet reported Response Pharmaceuticals 24 participants Est. completion 2023-09-13 1 siteOther conditions: Drug-induced Weight GainView official trial listing → -
Status unknown NCT NCT05872555
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
Mark Weiser, MD, Principal Investigator 22777 participants Est. completion 2025-01-01 1 siteOther conditions: Psychotic DisordersView official trial listing → -
Withdrawn NCT NCT05890768
Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine
Not yet reported University of New Mexico Est. completion 2024-02-28 1 siteOther conditions: PsychosisView official trial listing → -
Withdrawn NCT NCT05939765
Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.
Psychiatric University Hospital, Zurich Est. completion 2025-12-01 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT05946486
Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.
Not yet reported University Hospital, Bordeaux 174 participants Est. completion 2026-12-15 9 sitesOther conditions: Mental DisorderView official trial listing → -
Status unknown NCT NCT05964790
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
Not yet reported, Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 112 participants Est. completion 2024-12-30Other conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT06011408
Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes
Not yet reported iRxReminder 300 participants Est. completion 2024-12-31 2 sitesOther conditions: Tardive DyskinesiaView official trial listing → -
Completed NCT NCT06040944
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Fayoum University 64 participants Est. completion 2022-11-01 1 siteOther conditions: Schizophrenia Spectrum and Other Psychotic Disorders, Periodontal DiseasesView official trial listing → -
Status unknown NCT NCT06060886
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
Not yet reported Consorcio Centro de Investigación Biomédica en Red (CIBER) 244 participants Est. completion 2025-12-31MASLD Other conditions: Schizophrenia, Treatment-resistant Schizophrenia, Side Effect, Lipid Metabolism Disorders, Diabetes, PsychosisView official trial listing → -
Completed NCT NCT06067984
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia
Not yet reported Click Therapeutics, Inc. 73 participants Est. completion 2025-08-22 1 siteOther conditions: Schizophrenia, Negative Symptoms in SchizophreniaView official trial listing → -
Status unknown NCT NCT06107322
Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors
University Hospital, Strasbourg, France 20 participants Est. completion 2024-03-23 1 siteOther conditions: NeutropeniaView official trial listing → -
Withdrawn NCT NCT06107829
Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
Not yet reported Stephen Ruedrich Est. completion 2027-02 1 siteOther conditions: Tardive Dyskinesia, Intellectual Disability, Developmental DisabilitiesView official trial listing → -
Status unknown NCT NCT06125275
Pattern of Acute Antipsychotic Drug- Toxicity in Children
Assiut University 50 participants Est. completion 2026-02-28Other conditions: Antipsychotic Drug- ToxicityView official trial listing → -
Completed NCT NCT06136936
A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
Not yet reported Click Therapeutics, Inc. 53 participants Est. completion 2024-02-22 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT06159322
Characterizing Response to Antipsychotics in Schizophrenia
The Royal Ottawa Mental Health Centre 40 participants Est. completion 2024-01-30 1 siteOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Status unknown NCT NCT06160869
Effect of Acceptance and Commitment Therapy on Psychotic Severity
Not yet reported Port Said University 76 participants Est. completion 2023-12-20 1 siteOther conditions: Psychosis, Emotion Regulation, RecoveryView official trial listing → -
Completed NCT NCT06167577
Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150 participants Est. completion 2023-11-08 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT06179108
Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
Not yet reported LB Pharmaceuticals Inc. 359 participants Est. completion 2024-12-04 25 sitesOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT06200584
Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics
Not yet reported Dr Rabia Arshad 140 participants Est. completion 2021-06-10 1 siteOther conditions: Antipsychotics and Neuroleptics ToxicityView official trial listing → -
Completed NCT NCT06236451
Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 60 participants Est. completion 2025-11-12 1 siteOther conditions: SchizophreniaView official trial listing → -
Status unknown NCT NCT06238089
Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales
University of Plymouth 600 participants Est. completion 2024-04 8 sitesOther conditions: Intellectual DisabilityView official trial listing → -
Active, not recruiting NCT NCT06245213
A Study of ANAVEX3-71 in Adults With Schizophrenia
Not yet reported Anavex Life Sciences Corp. 71 participants Est. completion 2025-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Active, not recruiting NCT NCT06251635
Effects of Antipsychotics on Brain Insulin Action in Females
Not yet reported Centre for Addiction and Mental Health 15 participants Est. completion 2026-12-31 1 siteType 2 diabetes Other conditions: Insulin Resistance, Menstrual Cycle, AntipsychoticsView official trial listing → -
Status unknown NCT NCT06274255
Serum Magnesium Level and Pediatric Migraine
Mersin University 60 participants Est. completion 2024-05-15 4 sitesOther conditions: Migraine, Magnesium, PediatricView official trial listing → -
Active, not recruiting NCT NCT06278246
Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography
Centre for Addiction and Mental Health 58 participants Est. completion 2026-03 1 siteOther conditions: Schizophrenia, Schizophreniform DisordersView official trial listing → -
Status unknown NCT NCT06294353
Study of Efficacy and Safety of WELT-ED for Eating Disorder (WCTP-ED-B-01)
Not yet reported WELT corp 134 participants Est. completion 2024-08-30 2 sitesOther conditions: Eating Disorders, Binge Eating, Binge-Eating DisorderView official trial listing → -
Status unknown NCT NCT06301074
The Phase I Study of HS-10509 in Chinese Adult Subjects
Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 80 participants Est. completion 2024-10 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT06326840
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
Not yet reported Taipei Medical University Hospital 42 participants Est. completion 2011-06-10 1 siteOther conditions: Metabolic Disturbance, Hyperprolactinemia, SchizophreniaView official trial listing → -
Completed NCT NCT06331520
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Not yet reported Fudan University 644 participants Est. completion 2025-08-30 1 siteOther conditions: Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic ChemotherapyView official trial listing → -
Active, not recruiting NCT NCT06357195
DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Ohio State University 1000 participants Est. completion 2026-07-01 1 siteOther conditions: Emergency Psychiatric, Cognition Disorder, Movement Disorders, Antipsychotics and Neuroleptics Toxicity, Dementia With Lewy Bodies, Alteration in Mental Status, Behavior, AgingView official trial listing → -
Completed NCT NCT06410508
Evaluation of a Brief Intervention to Improve Engagement in Early Intervention Services for Psychosis
Not yet reported Nova Scotia Health Authority 33 participants Est. completion 2026-05-22 1 siteOther conditions: Psychotic Disorders, Psychiatric Hospitalization, Engagement, PatientView official trial listing → -
Active, not recruiting NCT NCT06433635
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
Not yet reported Massachusetts General Hospital 2726 participants Est. completion 2030-02-28 18 sitesOther conditions: Bipolar I Disorder, DepressionView official trial listing → -
Active, not recruiting NCT NCT06453174
CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project
Instituto de Investigación Biomédica de Salamanca 300 participants Est. completion 2026-12-31 1 siteOther conditions: PsychosisView official trial listing → -
Active, not recruiting NCT NCT06474195
Cue-based Intervention in Prospective Memory and Medication Adherence.
Not yet reported University of Pittsburgh 104 participants Est. completion 2026-09-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT06474286
Prucalopride for Cognitive Functioning in Schizophrenia
Not yet reported University of Pittsburgh 34 participants Est. completion 2028-12-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT06486948
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.
Not yet reported Click Therapeutics, Inc. 58 participants Est. completion 2024-08-09 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT06546475
A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine
Not yet reported National Taiwan University Hospital 20 participants Est. completion 2027-07-31Other conditions: PsychosisView official trial listing → -
Enrolling by invitation NCT NCT06558201
Open Label Extension Study of NCT06221852
Not yet reported Mclean Hospital 50 participants Est. completion 2027-12-30 1 siteOther conditions: Bipolar I Disorder, Schizoaffective Disorder, PsychosisView official trial listing → -
Status unknown NCT NCT06590298
Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females
Not yet reported Universiti Putra Malaysia 600 participants Est. completion 2025-04-10Metabolic syndrome Other conditions: Psychosis, Weight GainView official trial listing → -
Status unknown NCT NCT06643871
Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis
Not yet reported Centre Hospitalier St Anne 40 participants Est. completion 2025-12-01Other conditions: Schizophrenia; Psychosis, Schizo Affective Disorder, First Episode Psychosis (FEP)View official trial listing → -
Status unknown NCT NCT06650943
Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
Not yet reported Hospital de Basurto 88 participants Est. completion 2026-06-30 1 siteMetabolic syndrome Other conditions: First Episode Psychosis (FEP)View official trial listing → -
Not yet recruiting NCT NCT06695676
Effects of Lurasidone on Left Ventricle Systolic Functions
Aydin Adnan Menderes University 62 participants Est. completion 2025-06-01 1 siteOther conditions: Lurasidone Cardiotoxicity, Schizophrenia Patients, Bipolar DisordersView official trial listing → -
Status unknown NCT NCT06703827
Effects of Online Metacognitive Training Group on Distressing Beliefs
Not yet reported City, University of London 72 participants Est. completion 2025-09-27 1 siteOther conditions: PsychosisView official trial listing → -
Active, not recruiting NCT NCT06754163
Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients
Not yet reported St Andrew's Healthcare 20 participants Est. completion 2027-12-30 1 site Added to GLP-1Other conditions: Obesity and Obesity-related Medical Conditions, Psychiatric DisordersView official trial listing → -
Completed NCT NCT06787781
Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects
Not yet reported University of Messina 15 participants Est. completion 2021-12-31 1 siteOther conditions: Metabolic Evaluation, Cardiac ComplicationsView official trial listing → -
Completed NCT NCT06807242
Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )
Oslo University Hospital 270 participants Est. completion 2019-12 1 siteOther conditions: Schizophrenic Psychoses, Schizophrenia, Severe Mental DisorderView official trial listing → -
Active, not recruiting NCT NCT06838104
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial
Not yet reported Lahore General Hospital 76 participants Est. completion 2025-06-05 1 siteOther conditions: Schizophrenia Disorders, Psychotic DisorderView official trial listing → -
Active, not recruiting NCT NCT06869187
Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults
Not yet reported Autobahn Therapeutics, Inc. 35 participants Est. completion 2026-09-24 14 sitesOther conditions: Bipolar Disorder DepressionView official trial listing → -
Withdrawn NCT NCT06878833
A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
Not yet reported Lyndra Inc. Est. completion 2026-12-31Other conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Not yet recruiting NCT NCT06924255
An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia
Not yet reported Collaborative Neuroscience Research, LLC 100 participants Est. completion 2025-12 7 sitesOther conditions: Schizophrenia DisordersView official trial listing → -
Terminated NCT NCT06949657
Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and
Not yet reported Third People's Hospital, Huzhou City, Zhejiang Province, China 78 participants Est. completion 2024-09-19 1 siteOther conditions: Schizophrenia Disorders, Cognitive Impairment, Acceptance and Commitment TherapyView official trial listing → -
Completed NCT NCT06993662
The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.
Not yet reported Rakitzi, Stavroula 107 participants Est. completion 2026-08-03 1 siteOther conditions: Anxiety, Depression, Obsessive-compulsive Disorder, Personality Disorder, Bipolar Disorder, Schizophrenia, Psychotic Disorders, PTSDView official trial listing → -
Not yet recruiting NCT NCT07001878
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis
Not yet reported Nova Scotia Health Authority 24 participants Est. completion 2027-12-01 2 sitesOther conditions: Psychosis, Cannabis UseView official trial listing → -
Not yet recruiting NCT NCT07011693
Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression(SMART-I)
Not yet reported Xinyu Zhou 400 participants Est. completion 2027-12 1 siteOther conditions: Major Depressive Disorder (MDD)View official trial listing → -
Not yet recruiting NCT NCT07011953
A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia
Not yet reported Peking University 90 participants Est. completion 2027-07-01Other conditions: Schizophrenia, AvolitionView official trial listing → -
Not yet recruiting NCT NCT07024303
Measurement of Treatment Effects
Not yet reported Matthew J O'Brien, PhD, BCBA-D 20 participants Est. completion 2027-12-31Other conditions: Challenging Behavior, Autism Spectrum DisorderView official trial listing → -
Active, not recruiting NCT NCT07047651
Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.
Not yet reported Dr. Stavroula Rakitzi 84 participants Est. completion 2027-12-20 1 siteOther conditions: Treatment Resistant Schizophrenia, Treatment Resistant Bipolar DisorderView official trial listing → -
Not yet recruiting NCT NCT07075237
Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia
Not yet reported Jiangsu Province Nanjing Brain Hospital 120 participants Est. completion 2027-03 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07086040
Effects of RAS in SZ
Not yet reported Shu-Mei Wang 140 participants Est. completion 2028-07-31 1 siteOther conditions: Schizophrenia and Schizoaffective DisorderView official trial listing → -
Completed NCT NCT07102069
Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia
Tianjin Anding Hospital 384 participants Est. completion 2022-09-14 1 siteOther conditions: SchizophreniaView official trial listing → -
Enrolling by invitation NCT NCT07130500
Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization
Not yet reported Stanford University 1000 participants Est. completion 2030-03 6 sitesSubstance use disorder Other conditions: Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD)View official trial listing → -
Not yet recruiting NCT NCT07134816
Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder
Not yet reported University Hospital, Montpellier 240 participants Est. completion 2028-03 1 siteAlcohol use disorder Other conditions: Schizophrenia SpectrumView official trial listing → -
Not yet recruiting NCT NCT07152184
Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach
Not yet reported University Hospital, Strasbourg, France 288 participants Est. completion 2032-02-01Other conditions: Patient With Schizophrenia Spectrum Disorder, NLM Classification WM 203, Psychology:Schizophrenic Psychology, Schizophrenia Spectrum and Other Psychotic DisordersView official trial listing → -
Not yet recruiting NCT NCT07153835
Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study
Not yet reported Sher-E-Bangla Medical College 505 participants Est. completion 2026-07-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Enrolling by invitation NCT NCT07162467
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
Tianjin Anding Hospital 200 participants Est. completion 2026-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07206563
Penfluridol for Relapsed/Refractory Small Cell Cancers
Not yet reported, Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33 participants Est. completion 2028-10-01 1 siteOther conditions: Small Cell Carcinoma, Small Cell Carcinoma of Lung, Small Cell Lung Cancer ( SCLC ), Small Cell Cervical CarcinomaView official trial listing → -
Not yet recruiting NCT NCT07252752
Dopamine and Insulin in Psychosis
Not yet reported Medical University of Vienna 46 participants Est. completion 2029-01-01 1 siteOther conditions: First Episode Psychosis (FEP)View official trial listing → -
Not yet recruiting NCT NCT07342764
Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial
Not yet reported Sultan Qaboos University 110 participants Est. completion 2028-12 1 siteOther conditions: Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight GainView official trial listing → -
Active, not recruiting NCT NCT07351240
The Acupuncture Treatment Effect in Patients With Schizophrenia
Not yet reported Calo Psychiatric Center 100 participants Est. completion 2026-12-30 1 siteOther conditions: Mental HealthView official trial listing → -
Enrolling by invitation NCT NCT07356765
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
Not yet reported Tianjin Anding Hospital 120 participants Est. completion 2027-04-30 1 siteOther conditions: Schizophrenia, Negative Symptoms of SchizophreniaView official trial listing → -
Completed NCT NCT07359209
Berberine Improving Cognitive Impairments in Schizophrenia
Not yet reported Tianjin Anding Hospital 124 participants Est. completion 2026-04-23 1 siteOther conditions: Schizophrenia TherapeuticsView official trial listing → -
Completed NCT NCT07371325
Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.
Not yet reported Manuel Jesús Cuesta Zurita 36 participants Est. completion 2026-01-23 1 siteOther conditions: SCHIZOPHRENIA 1 (Disorder), Metabolic Abnormalities, Postbiotic SupplementView official trial listing → -
Not yet recruiting NCT NCT07386080
Carbergoline for Antipsychotic Induced Hyperprolactinemia.
Not yet reported Zealand University Hospital 146 participants Est. completion 2029-05-01 1 siteOther conditions: ScizophreniaView official trial listing → -
Not yet recruiting NCT NCT07386483
Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome
Not yet reported University College Dublin 40 participants Est. completion 2028-04-30 1 siteOther conditions: PsychosisView official trial listing → -
Completed NCT NCT07392489
Decreasing Harms and Improving Child Health
Not yet reported Glyn Jones-Elwyn 31 participants Est. completion 2025-02-12 4 sitesOther conditions: Psychotropic Drugs, Psychiatric Drugs, Children, Shared Decision Making, Patient Decision AidView official trial listing → -
Completed NCT NCT07432763
Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia
Not yet reported Panhellenic Federation of Alzheimer's Disease and Related Disorders 18 participants Est. completion 2024-10-31 1 siteOther conditions: Urinary Tract Infections (UTIs), Urinary Tract Infection, Recurrent, Antipsychotics Discontinuation, Antipsychotics TaperingView official trial listing → -
Completed NCT NCT07445217
Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia
Not yet reported Calo Psychiatric Center 763 participants Est. completion 2008-09-04 1 siteOther conditions: Functional OutcomesView official trial listing → -
Not yet recruiting NCT NCT07445802
Medication Adherence in Severe Mental Illness: a Promotion Program
Not yet reported Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 1640 participants Est. completion 2028-09Other conditions: Treatment Adherence and Compliance, Severe Mental Disorders, Bipolar Disorder (BD), Schizophrenia DisorderView official trial listing → -
Not yet recruiting NCT NCT07446218
Pharmacist-led Interventions in Psychiatric Patients
Not yet reported University of Lahore 148 participants Est. completion 2026-05-31 2 sitesMetabolic syndrome Other conditions: Mental DisordersView official trial listing → -
Enrolling by invitation NCT NCT07448675
Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness
Tianjin Anding Hospital 230 participants Est. completion 2026-06-30 1 siteOther conditions: Patients With Severe Mental IllnessView official trial listing → -
Not yet recruiting NCT NCT07515222
Efficacy of Yoga-Based Intervention in Improving Mother-Child Bonding in Maternal Depression
Not yet reported All India Institute of Medical Sciences 52 participants Est. completion 2027-05-15Other conditions: Perinatal Depression, Postpartum Depression, Mother-Infant Bonding DisorderView official trial listing → -
Completed NCT NCT07523256
Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia
Not yet reported Rinvil Renaldi 44 participants Est. completion 2026-01-31 1 siteOther conditions: Schizophrenia, Psychotic DisordersView official trial listing → -
Completed NCT NCT07524868
Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients
Not yet reported Hasanuddin University 50 participants Est. completion 2026-01-31 1 siteAlcohol use disorder Other conditions: Schizophrenia PatientsView official trial listing → -
Completed NCT NCT07541157
Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients
Not yet reported Hasanuddin University 80 participants Est. completion 2026-01-31 1 siteOther conditions: Schizophrenia PatientsView official trial listing → -
Withdrawn NCT NCT07548489
Phenobarbital for Agitated Delirium
Not yet reported Duke University Est. completion 2027-07 1 siteOther conditions: Agitated Delirium, Delirium Confusional State, Delirium in the Intensive Care Unit, Hyperactive DeliriumView official trial listing → -
Not yet recruiting NCT NCT07570875
Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area
Not yet reported University of Alabama at Birmingham 100 participants Est. completion 2027-11 1 siteOther conditions: Bipolar DisorderView official trial listing → -
Completed NCT NCT07575516
Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone
Not yet reported Hasanuddin University 80 participants Est. completion 2026-01-31 1 siteOther conditions: Schizophrenia Patients, NeuroinflammationView official trial listing → -
Completed NCT NCT07609953
Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia
Not yet reported Hasanuddin University 42 participants Est. completion 2026-01-31 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07656870
Exploring the Genetics of Schizophrenia in Manitoba
University of Manitoba 1500 participants Est. completion 2031-04 1 siteOther conditions: Schizophrenia, Healthy (Controls)View official trial listing → -
Not yet recruiting NCT NCT07665073
Risperidone vs Cariprazine in Acute Mania
Not yet reported Pakistan Institute of Medical Sciences 50 participants Est. completion 2028-06Other conditions: Bipolar 1 DisorderView official trial listing → -
Not yet recruiting NCT NCT07715253
Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia
Not yet reported New York State Psychiatric Institute 100 participants Est. completion 2030-11-30Other conditions: Schizoaffective Disorder, Schizophreniform Disorder, SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07715994
A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms
Shanghai Mental Health Center 180 participants Est. completion 2027-04 1 siteOther conditions: Extrapyramidal Symptoms, Drug-induced Parkinsonism, Akathisia, Drug-Induced, Tardive Dyskinesia (TD)View official trial listing → -
Not yet recruiting NCT NCT07767526
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Not yet reported, Not yet reported Shanghai Mental Health Center 46 participants Est. completion 2028-12-31 1 siteOther conditions: Schizophrenia, Antipsychotic DrugView official trial listing → -
Not yet recruiting NCT NCT07770282
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Not yet reported All India Institute of Medical Sciences, Bhubaneswar 600 participants Est. completion 2030-12-30Metabolic syndrome Other conditions: Schizophrenia Disorder, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin ResistanceView official trial listing → -
Active, not recruiting NCT NCT07783373
Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia
Bristol-Myers Squibb 3000 participants Est. completion 2028-04-26 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07791212
Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
King's College London 300 participants Est. completion 2036-10-01 2 sitesOther conditions: Neuropsychiatric SymptomView official trial listing → -
Not yet recruiting NCT NCT07802158
Discontinuing Psychotropic Medication Before Psychotherapy for PTSD
Academic Centre for Dentistry in Amsterdam 100 participants Est. completion 2026-09-02Other conditions: Post-traumatic Stress Disorder (PTSD)View official trial listing → -
Not yet recruiting NCT NCT07815587
Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers
St. Olavs Hospital 60 participants Est. completion 2027-12Other conditions: Psychotic Disorder, SCHIZOPHRENIA 1 (Disorder), Intramuscular InjectionView official trial listing → -
Not yet recruiting NCT NCT07820553
Building a Computational Model of Auditory Hallucinations
King's College London 146 participants Est. completion 2030-08Other conditions: Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophreni-form DisorderView official trial listing → -
Not yet recruiting NCT NCT07822295
The Effect of Chronic ssrı/snrı Antidepressant Treatment on Propofol Consumption in Elective Spine Surgery
Kocaeli City Hospital 216 participants Est. completion 2027-05-30 1 siteOther conditions: Chronic SSRI/SNRI Use and Intraoperative Propofol RequirementsView official trial listing → -
Completed NCT NCT07834112
Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder
Dong-Wook Kim 155 participants Est. completion 2025-12-31 1 siteOther conditions: Bipolar Disorder (BD)View official trial listing → -
Not yet recruiting NCT NCT07853079
Motivational Intervention for Patients With Schizophrenia
Not yet reported University of Geneva, Switzerland 88 participants Est. completion 2029-09-30Other conditions: Schizo-affective Disorder, Non Organic Psychosis, Schizophenia DisorderView official trial listing → -
Active, not recruiting NCT NCT07882589
Psychoactive Drug Use and Acute Care Use After Trauma and Out-of-Hospital Cardiac Arrest
Azienda Usl di Bologna 52720 participants Est. completion 2027-07-30 2 sitesOther conditions: Wounds and Injuries, Out-of-Hospital Cardiac Arrest, Traumatic Brain InjuryView official trial listing → -
Not yet recruiting NCT NCT07914192
Antipsychotic Safety and Adherence in Patients With Psychiatric Disorders-An Egyptian Institution-Based Cross-Sectional Study.
Egyptian Chinese University 250 participants Est. completion 2027-02-01Other conditions: Psychiatric DisorderView official trial listing → -
Completed NCT NCT07917637
Ashwagandha Added to Risperidone for Quality of Life and Inflammation in Schizophrenia
Not yet reported Athitah Pratiwi 60 participants Est. completion 2026-06-30 1 siteOther conditions: SchizophreniaView official trial listing → -
Not yet recruiting NCT NCT07921966
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
Not yet reported Neurelis, Inc. 24 participants Est. completion 2027-01-14Other conditions: Healthy Adult ParticipantsView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
